<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2215182-B1" country="EP" doc-number="2215182" kind="B1" date="20140108" family-id="40625953" file-reference-id="299959" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146588167" ucid="EP-2215182-B1"><document-id><country>EP</country><doc-number>2215182</doc-number><kind>B1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-08847358-A" is-representative="NO"><document-id mxw-id="PAPP154850359" load-source="docdb" format="epo"><country>EP</country><doc-number>08847358</doc-number><kind>A</kind><date>20081107</date><lang>KO</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140550135" ucid="KR-20070113852-A" load-source="docdb"><document-id format="epo"><country>KR</country><doc-number>20070113852</doc-number><kind>A</kind><date>20071108</date></document-id></priority-claim><priority-claim mxw-id="PPC140548953" ucid="KR-2008006588-W" load-source="docdb"><document-id format="epo"><country>KR</country><doc-number>2008006588</doc-number><kind>W</kind><date>20081107</date></document-id></priority-claim></priority-claims><dates-of-public-availability><intention-to-grant-date><date>20130913</date></intention-to-grant-date><search-report-dispatch-date><date>20110721</date></search-report-dispatch-date></dates-of-public-availability><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989324878" load-source="docdb">C07D 409/10        20060101ALI20130731BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989324879" load-source="docdb">C07D 409/14        20060101ALI20130731BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989324880" load-source="docdb">C09K  11/06        20060101AFI20130731BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989324881" load-source="docdb">H01L  51/00        20060101ALI20130731BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989324882" load-source="docdb">H01L  51/50        20060101ALI20130731BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-2087980653" load-source="docdb" scheme="CPC">C09K2211/1011      20130101 LA20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087981497" load-source="docdb" scheme="CPC">C09K  11/06        20130101 FI20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087981841" load-source="docdb" scheme="CPC">C09K2211/1029      20130101 LA20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087982032" load-source="docdb" scheme="CPC">C09K2211/1007      20130101 LA20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087982916" load-source="docdb" scheme="CPC">H01L  51/0061      20130101 LI20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087984094" load-source="docdb" scheme="CPC">C07D 409/10        20130101 LI20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087984271" load-source="docdb" scheme="CPC">H01L  51/5012      20130101 LA20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087985042" load-source="docdb" scheme="CPC">H01L  51/0072      20130101 LI20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087985356" load-source="docdb" scheme="CPC">C07D 409/14        20130101 LI20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087987337" load-source="docdb" scheme="CPC">C09K2211/1014      20130101 LA20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087988313" load-source="docdb" scheme="CPC">C09K2211/1092      20130101 LA20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087988650" load-source="docdb" scheme="CPC">H01L  51/5048      20130101 LA20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087989696" load-source="docdb" scheme="CPC">H01L  51/0068      20130101 LA20150305BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2087991233" load-source="docdb" scheme="CPC">H01L  51/5088      20130101 LA20150305BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132369134" lang="DE" load-source="patent-office">CARBAZOLDERIVAT UND DAVON GEBRAUCH MACHENDE ORGANISCHE LICHTEMITTIERENDE VORRICHTUNG</invention-title><invention-title mxw-id="PT132369135" lang="EN" load-source="patent-office">CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING SAME</invention-title><invention-title mxw-id="PT132369136" lang="FR" load-source="patent-office">DERIVE DE CARBAZOLE ET DISPOSITIF ELECTROLUMINESCENT ORGANIQUE UTILISANT LEDIT DERIVE</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR919515652" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>LG CHEMICAL LTD</last-name><address><country>KR</country></address></addressbook></applicant><applicant mxw-id="PPAR919510904" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>LG CHEM, LTD.</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919541050" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>HONG SUNG-KIL</last-name><address><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919515917" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>HONG, SUNG-KIL</last-name></addressbook></inventor><inventor mxw-id="PPAR919021822" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>HONG, SUNG-KIL</last-name><address><street>7-405 LG Partner Apt. Doryong-dong Yuseong-gu</street><city>Daejeon, Metropolitan City 305-340</city><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919523798" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>CHO WOOK-DONG</last-name><address><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919536166" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>CHO, WOOK-DONG</last-name></addressbook></inventor><inventor mxw-id="PPAR919021820" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>CHO, WOOK-DONG</last-name><address><street>203-1001 Expo Apt. Jeonmin-dong Yuseong-gu</street><city>Daejeon, Metropolitan City 305-761</city><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919510862" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>BAE JAE-SOON</last-name><address><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919504986" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>BAE, JAE-SOON</last-name></addressbook></inventor><inventor mxw-id="PPAR919021816" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>BAE, JAE-SOON</last-name><address><street>106-305 Expo Apt. Jeonmin-dong Yuseong-gu</street><city>Daejeon, Metropolitan City 305-761</city><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919531375" load-source="docdb" sequence="4" format="epo"><addressbook><last-name>KIM JI-EUN</last-name><address><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919522281" load-source="docdb" sequence="4" format="intermediate"><addressbook><last-name>KIM, JI-EUN</last-name></addressbook></inventor><inventor mxw-id="PPAR919021817" load-source="patent-office" sequence="4" format="original"><addressbook><last-name>KIM, JI-EUN</last-name><address><street>7-403 LG Chemistry Partner Apt. 381-42 Doryong-dong Yuseong-gu</street><city>Daejeon, Metropolitan City 305-340</city><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919531750" load-source="docdb" sequence="5" format="epo"><addressbook><last-name>NAM HYUN</last-name><address><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919509941" load-source="docdb" sequence="5" format="intermediate"><addressbook><last-name>NAM, HYUN</last-name></addressbook></inventor><inventor mxw-id="PPAR919021818" load-source="patent-office" sequence="5" format="original"><addressbook><last-name>NAM, HYUN</last-name><address><street>9-203 LG Chemistry Partner Apt. 386-1 Doryong-dong Yuseong-gu</street><city>Daejeon, Metropolitan City 305-340</city><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919537729" load-source="docdb" sequence="6" format="epo"><addressbook><last-name>JANG JUN-GI</last-name><address><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919520142" load-source="docdb" sequence="6" format="intermediate"><addressbook><last-name>JANG, JUN-GI</last-name></addressbook></inventor><inventor mxw-id="PPAR919021819" load-source="patent-office" sequence="6" format="original"><addressbook><last-name>JANG, JUN-GI</last-name><address><street>101-708 Sejong Apt. Jeonmin-dong Yuseong-gu</street><city>Daejeon, Metropolitan City 305-728</city><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919519936" load-source="docdb" sequence="7" format="epo"><addressbook><last-name>JEON BYUNG-SUN</last-name><address><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919517603" load-source="docdb" sequence="7" format="intermediate"><addressbook><last-name>JEON, BYUNG-SUN</last-name></addressbook></inventor><inventor mxw-id="PPAR919021821" load-source="patent-office" sequence="7" format="original"><addressbook><last-name>JEON, BYUNG-SUN</last-name><address><street>1006 Taeyoung Apt. Sillim 5-dong Gwanak-gu</street><city>Seoul 151-708</city><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919521521" load-source="docdb" sequence="8" format="epo"><addressbook><last-name>JOO MUN-KYU</last-name><address><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919504947" load-source="docdb" sequence="8" format="intermediate"><addressbook><last-name>JOO, MUN-KYU</last-name></addressbook></inventor><inventor mxw-id="PPAR919021824" load-source="patent-office" sequence="8" format="original"><addressbook><last-name>JOO, MUN-KYU</last-name><address><street>7/2, 1619-468 Daeyeon 2-dong Nam-gu</street><city>Busan 608-022</city><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919529965" load-source="docdb" sequence="9" format="epo"><addressbook><last-name>JANG HYE-YOUNG</last-name><address><country>KR</country></address></addressbook></inventor><inventor mxw-id="PPAR919529784" load-source="docdb" sequence="9" format="intermediate"><addressbook><last-name>JANG, HYE-YOUNG</last-name></addressbook></inventor><inventor mxw-id="PPAR919021823" load-source="patent-office" sequence="9" format="original"><addressbook><last-name>JANG, HYE-YOUNG</last-name><address><street>833 Anusvill 1380-1 Dunsan-dong Seo-gu</street><city>Daejeon, Metropolitan City 302-120</city><country>KR</country></address></addressbook></inventor></inventors><assignees><assignee mxw-id="PPAR919021826" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>LG Chem, Ltd.</last-name><iid>101096435</iid><address><street>20, Yoido-dong</street><city>Youngdungpo-gu Seoul 150-721</city><country>KR</country></address></addressbook></assignee></assignees><agents><agent mxw-id="PPAR919021825" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>HOFFMANN EITLE</last-name><iid>100061036</iid><address><street>Patent- und Rechtsanwälte Arabellastrasse 4</street><city>81925 München</city><country>DE</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="KR-2008006588-W"><document-id><country>KR</country><doc-number>2008006588</doc-number><kind>W</kind><date>20081107</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2009061156-A1"><document-id><country>WO</country><doc-number>2009061156</doc-number><kind>A1</kind><date>20090514</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS549782131" load-source="docdb">AT</country><country mxw-id="DS549870562" load-source="docdb">BE</country><country mxw-id="DS549867787" load-source="docdb">BG</country><country mxw-id="DS549890023" load-source="docdb">CH</country><country mxw-id="DS549783317" load-source="docdb">CY</country><country mxw-id="DS549782132" load-source="docdb">CZ</country><country mxw-id="DS549870563" load-source="docdb">DE</country><country mxw-id="DS549783318" load-source="docdb">DK</country><country mxw-id="DS549783319" load-source="docdb">EE</country><country mxw-id="DS549799264" load-source="docdb">ES</country><country mxw-id="DS549867788" load-source="docdb">FI</country><country mxw-id="DS549874476" load-source="docdb">FR</country><country mxw-id="DS549870564" load-source="docdb">GB</country><country mxw-id="DS549783320" load-source="docdb">GR</country><country mxw-id="DS549870565" load-source="docdb">HR</country><country mxw-id="DS549782149" load-source="docdb">HU</country><country mxw-id="DS549890024" load-source="docdb">IE</country><country mxw-id="DS549783329" load-source="docdb">IS</country><country mxw-id="DS549874477" load-source="docdb">IT</country><country mxw-id="DS549783330" load-source="docdb">LI</country><country mxw-id="DS549867789" load-source="docdb">LT</country><country mxw-id="DS549922969" load-source="docdb">LU</country><country mxw-id="DS549867794" load-source="docdb">LV</country><country mxw-id="DS549867795" load-source="docdb">MC</country><country mxw-id="DS549922970" load-source="docdb">MT</country><country mxw-id="DS549799285" load-source="docdb">NL</country><country mxw-id="DS549874482" load-source="docdb">NO</country><country mxw-id="DS549922971" load-source="docdb">PL</country><country mxw-id="DS549890029" load-source="docdb">PT</country><country mxw-id="DS549799286" load-source="docdb">RO</country><country mxw-id="DS549922972" load-source="docdb">SE</country><country mxw-id="DS549870570" load-source="docdb">SI</country><country mxw-id="DS549874483" load-source="docdb">SK</country><country mxw-id="DS549783331" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><description mxw-id="PDES63960595" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001">[Technical Field]</heading><p id="p0001" num="0001">The present invention relates to an organic light emitting device in which a novel compound that is capable of largely improving a life span, efficiency, electrochemical stability and thermal stability of the organic light emitting device is included in an organic compound layer. This application claims priority from Korean Patent Application No. <patcit id="pcit0001" dnum="KR1020070113852"><text>10-2007-0113852 filed on November 18, 2007</text></patcit>, in the KIP0; the disclosure of which is incorporated herein by reference in its entirety.</p><heading id="h0002">[Background Art]</heading><p id="p0002" num="0002">An organic light emission phenomenon is an example of a conversion of current into visible rays through an internal process of a specific organic molecule. The organic light emission phenomenon is based on the following mechanism. When organic material layers are interposed between an anode and a cathode, if voltage is applied between the two electrodes, electrons and holes are injected from the cathode and the anode into the organic material layer. The electrons and the holes which are injected into the organic material layer are recombined to form an exciton, and<!-- EPO <DP n="2"> --> the exciton is reduced to a bottom state to emit light. An organic light emitting device which is based on the above mechanism typiccollectivelyy comprises a cathode, an anode, and organic material layer(s), for example, organic material layers including a hole inject ion layer, a hole transport layer, a light emitting layer, and an electron transport layer, interposed therebetween.</p><p id="p0003" num="0003">The materials used in the organic light emitting device are mostly pure organic materials or complexes of organic material and metal. The material used in the organic light emitting device may be classified as a hole injection material, a hole transport material, a light emitting material, an electron transport material, or an electron injection material, according to its use. In connection with this, an organic material having a p-type property, which is easily oxidized and is electrochemiccollectivelyy stable when it is oxidized, is mostly used as the hole injection material or the hole transport material. Meanwhile, an organic material having an n-type property, which is easily reduced and is electrochemiccollectivelyy stable when it is reduced, is used as the electron injection material or the electron transport material. As the light emitting layer material, an organic material having both p-type and n-type properties is preferable, which is stable when it is oxidized<!-- EPO <DP n="3"> --> and when it is reduced. Also a material having high light emission efficiency for conversion of the exciton into light when the exciton is formed is preferable.</p><p id="p0004" num="0004">In addition, it is preferable that the material used in the organic light emitting device further have the following properties.</p><p id="p0005" num="0005">First, it is preferable that the material used in the organic light emitting device have excellent thermal stability. The reason is that joule heat is generated by movement of electric charges in the organic light emitting device. NPB, which has recently been used as the hole transport layer material, has a glass transition temperature of 100°C or lower, thus it is difficult to apply to an organic light emitting device requiring a high current.</p><p id="p0006" num="0006">Second, in order to produce an organic light emitting device that is capable of being actuated at low voltage and has high efficiency, holes and electrons which are injected into the organic light emitting device must be smoothly transported to a light emitting layer, and must not be released out of the light emitting layer. To achieve this, a material used in the organic light emitting device must have a proper band gap and a proper HOMO or LUMO energy levels. A LUMO energy level of PEDOT:PSS, which is currently used as a hole transport material of an organic light<!-- EPO <DP n="4"> --> emitting device produced using a solution coating method, is lower than that of an organic material used as a light emitting layer material, thus it is difficult to produce an organic light emitting device having high efficiency and a long lifespan.</p><p id="p0007" num="0007">Moreover, the material used in the organic light emitting device must have excellent chemical stability, electric charge mobility, and interfacial characteristic with an electrode or an adjacent layer. That is to say, the material used in the organic light emitting device must be little deformed by moisture or oxygen. Furthermore, proper hole or electron mobility must be assured so as to balance densities of the holes and of the.electrons in the light emitting layer of the organic light emitting device to maximize the formation of excitons. Additionally, it has to be able to have a good interface with an electrode including metal or metal oxides so as to assure stability of the device.</p><p id="p0008" num="0008">Accordingly, there is a need to develop an organic material having the above-mentioned requirements in the art.</p><p id="p0009" num="0009"><patcit id="pcit0002" dnum="US20040086745A1"><text>US 2004/0086745 A1</text></patcit> describes a material for organic electroluminescence devices comprising a compound in which a heterocyclic group having nitrogen is bonded to an arylcarbazolyl group or a carbazolylalkylene group. Thus an organic electroluminescence device emitting blue light with a high efficiency of light emission and excellent purity of color can be obtained.<!-- EPO <DP n="5"> --></p><heading id="h0003">[Disclosure]</heading><heading id="h0004">[Technical Problem]</heading><p id="p0010" num="0010">The present inventors aim to provide an organic light emitting device that includes a heterocompound derivative which is capable<!-- EPO <DP n="6"> --> of satisfying conditions required of a material which may be used for an organic light emitting device, for example, a proper energy level, electrochemical stability, and thermal stability, and which has a chemical structure capable of playing various roles required for the organic light emitting device, depending on a substituent group.</p><heading id="h0005">[Technical Solution]</heading><p id="p0011" num="0011">The present invention provides a compound of the following Formula 1, Formula 3, Formula 4 or Formula 5 as defined below.</p><p id="p0012" num="0012">In addition, the present invention provides an organic light emitting device which comprises a first electrode, organic material layer(s) having one or more layers and comprising a light emitting layer, and a second electrode, wherein the first electrode, the organic material layer(s), and the second electrode form a layered structure and at least one layer of the organic material layer(s) includes a compound of the following Formula 1 or a compound of Formula 1 into which a thermosetting or photo-crosslinkable functional group is introduced.
<chemistry id="chem0001" num="0001"><img id="ib0001" file="imgb0001.tif" wi="61" he="43" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="7"> -->
wherein X is -(A<sub>m</sub>)-(B)<sub>n</sub>,<br/>
Y is an arylamine group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group; or a hetero ring group including O, N or S as a heteroatom, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group;<br/>
Ar is an arylene group having 6 to 40 carbon atoms, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of nitro, nitrile, halogen, an alkyl group, an alkoxy group and an amino group; or a divalent hetero ring group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of nitro, nitrile, halogen, an alkyl group, an alkoxy group and an amino group;<br/>
<!-- EPO <DP n="8"> -->A is an aryl group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group,<br/>
B is a hetero ring group including O or S as a heteroatom, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group,<br/>
<!-- EPO <DP n="9"> -->m and n are an integer in the range of 1 to 10 and an integer in the range of 0 to 10, respectively, and<br/>
R1 to R7 are each independently selected from the group consisting of hydrogen; an alkyl group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a<!-- EPO <DP n="10"> --> substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group; an alkoxy group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group; an aryl group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group; an amino group, which is substituted with one or more substituent groups selected from the group consisting of an alkyl group, an alkenyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, and a substituted or unsubstituted arylalkenyl group; a nitro group; and a halogen group, and said R1 to R7 may form an aliphatic or hetero condensation ring in conjunction with adjacent groups.<!-- EPO <DP n="11"> --></p><heading id="h0006">[Advantageous Effects]</heading><p id="p0013" num="0013">A compound according to the present invention may be used as an organic material layer material, particularly, a hole injection material and/or a hole transport material in an organic light emitting device, and in the case of when it is used in the organic light emitting device, a driving voltage of the device may be reduced, light efficiency may be improved, and a life span property of the device may be improved because of thermal stability of the compound.</p><heading id="h0007">[Description of Drawings]</heading><p id="p0014" num="0014"><ul><li><figref idrefs="f0001">FIG. 1</figref> illustrates an organic light emitting device comprising a substrate 1, an anode 2, a light emitting layer 3, and a cathode 4; and</li><li><figref idrefs="f0001">FIG. 2</figref> illustrates an organic light emitting device comprising a substrate 1, an anode 2, a hole injection layer 5, a hole transport layer 6, a light emitting layer 7, an electron transport layer 8, and a cathode 4.</li></ul></p><heading id="h0008">[Best Mode]</heading><p id="p0015" num="0015">A substituent group of Formula 1 will be described in detail below.</p><p id="p0016" num="0016">In R1 to R7 of Formula 1, the number of carbon atoms of the alkyl group, the alkoxy group, and the alkenyl group is not particularly limited, but it is preferable that it is in the range of 1 to 20.<!-- EPO <DP n="12"> --></p><p id="p0017" num="0017">The length of the alkyl group that is included in the compound does not affect the conjugation length of the compound, but may auxiliarily affect an application method of the compound to the organic light emitting device, for example, the application of a vacuum deposition method or a solution coating method.</p><p id="p0018" num="0018">Illustrative, but non-limiting, examples of the aryl group of R1 to R7 of Formula 1 include monocyclic aromatic rings, such as a phenyl group, a biphenyl group, a terphenyl group, and a stilbene group, and multicyclic aromatic rings, such as a naphthyl group, an anthracenyl group, a phenanthrene group, a pyrenyl group, and a perylenyl group.</p><p id="p0019" num="0019">Illustrative, but non-limiting, examples of the hetero ring group of R1 to R7 of Formula 1 include a thiophenyl group, a furan group, a pyrrolyl group, an imidazolyl group, a thiazolyl group, an oxazolyl group, an oxadiazolyl group, a triazolyl group, a pyridyl group, a pyradazine group, a quinolinyl group, an isoquinoline group, and an acridyl group.</p><p id="p0020" num="0020">A of Formula 1 is an aryl group, and preferably, illustrative, but non-limiting, examples thereof include monocyclic aromatic rings, such as a phenyl group, a biphenyl group, a terphenyl group, and a stilbene group, and multicyclic aromatic rings, such as a naphthyl group, an anthracenyl group, a phenanthrene group, a pyrenyl group, and a perylenyl<!-- EPO <DP n="13"> --> group.</p><p id="p0021" num="0021">Illustrative but non-limiting, examples of the heteroring of B include a thiophenyl group, a furan group, a pyrrolyl group, an imidazolyl group, a thiazolyl group, an oxazolyl group, an oxadiazolyl group, a triazolyl group, a pyridyl group, a pyradazine group, a quinolinyl group, an isoquinoline group, and an acridyl group.</p><p id="p0022" num="0022">The present invention also relates to a compound that is represented by any one of the following Formula 2 and Formula 3.
<chemistry id="chem0002" num="0002"><img id="ib0002" file="imgb0002.tif" wi="111" he="65" img-content="chem" img-format="tif"/></chemistry></p><p id="p0023" num="0023">In Formula 2 and Formula 3, Ar' s are each independently selected from the group consisting of a phenyl group, a biphenyl group, a terphenyl group, a stilbene group, a naphthyl group, an anthracenyl group, a phenanthrene group, a pyrenyl group, a perylenyl group, and Ar, Y and R1<!-- EPO <DP n="14"> --> to R8 are the same as definitions in respects to Ar, Y and R1 to R7 of Formula 1.</p><p id="p0024" num="0024">In addition, the compound that is represented by Formula 1 may be preferably a compound that is represented by any one of the following Formula 2-1 and Formula 3-1.
<chemistry id="chem0003" num="0003"><img id="ib0003" file="imgb0003.tif" wi="117" he="68" img-content="chem" img-format="tif"/></chemistry></p><p id="p0025" num="0025">In Formula 2-1 and Formula 3-1, Ar, Y and R1 to R8 are the same as definitions in respects to Ar, Y and R1 to R7 of Formula 1.</p><p id="p0026" num="0026">In addition, the compound that is represented by Formula 1 may be preferably a compound that is represented by any one of the following Formula 2-2 and Formula 3-2.
<chemistry id="chem0004" num="0004"><img id="ib0004" file="imgb0004.tif" wi="97" he="5" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="15"> -->
<chemistry id="chem0005" num="0005"><img id="ib0005" file="imgb0005.tif" wi="112" he="56" img-content="chem" img-format="tif"/></chemistry></p><p id="p0027" num="0027">In Formula 2-2 and Formula 3-2, Ar, Y and R1 to R8 are the same as definitions in respects to Ar, Y and R1 to R7 of Formula 1.</p><p id="p0028" num="0028">In addition, in the case of arylamine, illustrative, but non-limiting examples thereof may preferably include the following groups.
<chemistry id="chem0006" num="0006"><img id="ib0006" file="imgb0006.tif" wi="153" he="34" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0007" num="0007"><img id="ib0007" file="imgb0007.tif" wi="155" he="43" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="16"> -->
<chemistry id="chem0008" num="0008"><img id="ib0008" file="imgb0008.tif" wi="155" he="34" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0009" num="0009"><img id="ib0009" file="imgb0009.tif" wi="155" he="31" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0010" num="0010"><img id="ib0010" file="imgb0010.tif" wi="154" he="25" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0011" num="0011"><img id="ib0011" file="imgb0011.tif" wi="154" he="38" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0012" num="0012"><img id="ib0012" file="imgb0012.tif" wi="154" he="44" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="17"> -->
<chemistry id="chem0013" num="0013"><img id="ib0013" file="imgb0013.tif" wi="155" he="43" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0014" num="0014"><img id="ib0014" file="imgb0014.tif" wi="154" he="36" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0015" num="0015"><img id="ib0015" file="imgb0015.tif" wi="155" he="42" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0016" num="0016"><img id="ib0016" file="imgb0016.tif" wi="155" he="33" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0017" num="0017"><img id="ib0017" file="imgb0017.tif" wi="132" he="40" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="18"> -->
<chemistry id="chem0018" num="0018"><img id="ib0018" file="imgb0018.tif" wi="154" he="46" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0019" num="0019"><img id="ib0019" file="imgb0019.tif" wi="155" he="43" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0020" num="0020"><img id="ib0020" file="imgb0020.tif" wi="155" he="49" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0021" num="0021"><img id="ib0021" file="imgb0021.tif" wi="154" he="47" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="19"> -->
<chemistry id="chem0022" num="0022"><img id="ib0022" file="imgb0022.tif" wi="154" he="47" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0023" num="0023"><img id="ib0023" file="imgb0023.tif" wi="155" he="56" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0024" num="0024"><img id="ib0024" file="imgb0024.tif" wi="154" he="51" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0025" num="0025"><img id="ib0025" file="imgb0025.tif" wi="155" he="48" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="20"> -->
<chemistry id="chem0026" num="0026"><img id="ib0026" file="imgb0026.tif" wi="155" he="57" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0027" num="0027"><img id="ib0027" file="imgb0027.tif" wi="154" he="54" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0028" num="0028"><img id="ib0028" file="imgb0028.tif" wi="154" he="49" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0029" num="0029"><img id="ib0029" file="imgb0029.tif" wi="155" he="57" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="21"> -->
<chemistry id="chem0030" num="0030"><img id="ib0030" file="imgb0030.tif" wi="155" he="55" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0031" num="0031"><img id="ib0031" file="imgb0031.tif" wi="154" he="52" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0032" num="0032"><img id="ib0032" file="imgb0032.tif" wi="155" he="51" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0033" num="0033"><img id="ib0033" file="imgb0033.tif" wi="155" he="48" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="22"> -->
<chemistry id="chem0034" num="0034"><img id="ib0034" file="imgb0034.tif" wi="154" he="49" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0035" num="0035"><img id="ib0035" file="imgb0035.tif" wi="154" he="54" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0036" num="0036"><img id="ib0036" file="imgb0036.tif" wi="154" he="49" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0037" num="0037"><img id="ib0037" file="imgb0037.tif" wi="155" he="46" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="23"> -->
<chemistry id="chem0038" num="0038"><img id="ib0038" file="imgb0038.tif" wi="155" he="56" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0039" num="0039"><img id="ib0039" file="imgb0039.tif" wi="155" he="54" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0040" num="0040"><img id="ib0040" file="imgb0040.tif" wi="153" he="50" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="24"> -->
<chemistry id="chem0041" num="0041"><img id="ib0041" file="imgb0041.tif" wi="153" he="55" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0042" num="0042"><img id="ib0042" file="imgb0042.tif" wi="155" he="54" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0043" num="0043"><img id="ib0043" file="imgb0043.tif" wi="154" he="49" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0044" num="0044"><img id="ib0044" file="imgb0044.tif" wi="154" he="56" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="25"> -->
<chemistry id="chem0045" num="0045"><img id="ib0045" file="imgb0045.tif" wi="155" he="54" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0046" num="0046"><img id="ib0046" file="imgb0046.tif" wi="153" he="51" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0047" num="0047"><img id="ib0047" file="imgb0047.tif" wi="155" he="55" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0048" num="0048"><img id="ib0048" file="imgb0048.tif" wi="155" he="53" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="26"> -->
<chemistry id="chem0049" num="0049"><img id="ib0049" file="imgb0049.tif" wi="155" he="51" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0050" num="0050"><img id="ib0050" file="imgb0050.tif" wi="155" he="50" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0051" num="0051"><img id="ib0051" file="imgb0051.tif" wi="155" he="52" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0052" num="0052"><img id="ib0052" file="imgb0052.tif" wi="154" he="49" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="27"> -->
<chemistry id="chem0053" num="0053"><img id="ib0053" file="imgb0053.tif" wi="154" he="47" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0054" num="0054"><img id="ib0054" file="imgb0054.tif" wi="155" he="57" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0055" num="0055"><img id="ib0055" file="imgb0055.tif" wi="155" he="57" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0056" num="0056"><img id="ib0056" file="imgb0056.tif" wi="154" he="54" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="28"> -->
<chemistry id="chem0057" num="0057"><img id="ib0057" file="imgb0057.tif" wi="155" he="61" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0058" num="0058"><img id="ib0058" file="imgb0058.tif" wi="154" he="52" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0059" num="0059"><img id="ib0059" file="imgb0059.tif" wi="154" he="46" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0060" num="0060"><img id="ib0060" file="imgb0060.tif" wi="154" he="45" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="29"> -->
<chemistry id="chem0061" num="0061"><img id="ib0061" file="imgb0061.tif" wi="155" he="52" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0062" num="0062"><img id="ib0062" file="imgb0062.tif" wi="156" he="45" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0063" num="0063"><img id="ib0063" file="imgb0063.tif" wi="154" he="44" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0064" num="0064"><img id="ib0064" file="imgb0064.tif" wi="153" he="57" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="30"> -->
<chemistry id="chem0065" num="0065"><img id="ib0065" file="imgb0065.tif" wi="153" he="59" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0066" num="0066"><img id="ib0066" file="imgb0066.tif" wi="155" he="53" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0067" num="0067"><img id="ib0067" file="imgb0067.tif" wi="155" he="55" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="31"> -->
<chemistry id="chem0068" num="0068"><img id="ib0068" file="imgb0068.tif" wi="154" he="59" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0069" num="0069"><img id="ib0069" file="imgb0069.tif" wi="154" he="62" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0070" num="0070"><img id="ib0070" file="imgb0070.tif" wi="155" he="57" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="32"> -->
<chemistry id="chem0071" num="0071"><img id="ib0071" file="imgb0071.tif" wi="155" he="58" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0072" num="0072"><img id="ib0072" file="imgb0072.tif" wi="154" he="60" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0073" num="0073"><img id="ib0073" file="imgb0073.tif" wi="153" he="62" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="33"> -->
<chemistry id="chem0074" num="0074"><img id="ib0074" file="imgb0074.tif" wi="155" he="58" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0075" num="0075"><img id="ib0075" file="imgb0075.tif" wi="155" he="57" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0076" num="0076"><img id="ib0076" file="imgb0076.tif" wi="154" he="65" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="34"> -->
<chemistry id="chem0077" num="0077"><img id="ib0077" file="imgb0077.tif" wi="153" he="69" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0078" num="0078"><img id="ib0078" file="imgb0078.tif" wi="155" he="62" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0079" num="0079"><img id="ib0079" file="imgb0079.tif" wi="155" he="63" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="35"> -->
<chemistry id="chem0080" num="0080"><img id="ib0080" file="imgb0080.tif" wi="154" he="66" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0081" num="0081"><img id="ib0081" file="imgb0081.tif" wi="154" he="69" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0082" num="0082"><img id="ib0082" file="imgb0082.tif" wi="152" he="62" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="36"> -->
<chemistry id="chem0083" num="0083"><img id="ib0083" file="imgb0083.tif" wi="155" he="68" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0084" num="0084"><img id="ib0084" file="imgb0084.tif" wi="154" he="58" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0085" num="0085"><img id="ib0085" file="imgb0085.tif" wi="153" he="62" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="37"> -->
<chemistry id="chem0086" num="0086"><img id="ib0086" file="imgb0086.tif" wi="155" he="57" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0087" num="0087"><img id="ib0087" file="imgb0087.tif" wi="155" he="57" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0088" num="0088"><img id="ib0088" file="imgb0088.tif" wi="155" he="57" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="38"> -->
<chemistry id="chem0089" num="0089"><img id="ib0089" file="imgb0089.tif" wi="153" he="58" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0090" num="0090"><img id="ib0090" file="imgb0090.tif" wi="155" he="53" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0091" num="0091"><img id="ib0091" file="imgb0091.tif" wi="154" he="56" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="39"> -->
<chemistry id="chem0092" num="0092"><img id="ib0092" file="imgb0092.tif" wi="154" he="64" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0093" num="0093"><img id="ib0093" file="imgb0093.tif" wi="153" he="66" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0094" num="0094"><img id="ib0094" file="imgb0094.tif" wi="155" he="62" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="40"> -->
<chemistry id="chem0095" num="0095"><img id="ib0095" file="imgb0095.tif" wi="155" he="65" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0096" num="0096"><img id="ib0096" file="imgb0096.tif" wi="153" he="65" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0097" num="0097"><img id="ib0097" file="imgb0097.tif" wi="153" he="69" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="41"> -->
<chemistry id="chem0098" num="0098"><img id="ib0098" file="imgb0098.tif" wi="155" he="65" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0099" num="0099"><img id="ib0099" file="imgb0099.tif" wi="155" he="65" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0100" num="0100"><img id="ib0100" file="imgb0100.tif" wi="155" he="60" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="42"> -->
<chemistry id="chem0101" num="0101"><img id="ib0101" file="imgb0101.tif" wi="154" he="65" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0102" num="0102"><img id="ib0102" file="imgb0102.tif" wi="155" he="58" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0103" num="0103"><img id="ib0103" file="imgb0103.tif" wi="154" he="60" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="43"> -->
<chemistry id="chem0104" num="0104"><img id="ib0104" file="imgb0104.tif" wi="159" he="63" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0105" num="0105"><img id="ib0105" file="imgb0105.tif" wi="155" he="65" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0106" num="0106"><img id="ib0106" file="imgb0106.tif" wi="154" he="65" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="44"> -->
<chemistry id="chem0107" num="0107"><img id="ib0107" file="imgb0107.tif" wi="155" he="61" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0108" num="0108"><img id="ib0108" file="imgb0108.tif" wi="155" he="61" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0109" num="0109"><img id="ib0109" file="imgb0109.tif" wi="155" he="61" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="45"> -->
<chemistry id="chem0110" num="0110"><img id="ib0110" file="imgb0110.tif" wi="155" he="62" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0111" num="0111"><img id="ib0111" file="imgb0111.tif" wi="154" he="56" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0112" num="0112"><img id="ib0112" file="imgb0112.tif" wi="154" he="57" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="46"> -->
<chemistry id="chem0113" num="0113"><img id="ib0113" file="imgb0113.tif" wi="155" he="63" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0114" num="0114"><img id="ib0114" file="imgb0114.tif" wi="155" he="65" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0115" num="0115"><img id="ib0115" file="imgb0115.tif" wi="155" he="60" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="47"> -->
<chemistry id="chem0116" num="0116"><img id="ib0116" file="imgb0116.tif" wi="154" he="64" img-content="chem" img-format="tif"/></chemistry></p><p id="p0029" num="0029">Ar may be preferably phenylene.</p><p id="p0030" num="0030">The compound of Formula 1 may be preferably a compound that is represented by the following Formula 4 to Formula 12.
<chemistry id="chem0117" num="0117"><img id="ib0117" file="imgb0117.tif" wi="53" he="50" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0118" num="0118"><img id="ib0118" file="imgb0118.tif" wi="53" he="61" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="48"> -->
<chemistry id="chem0119" num="0119"><img id="ib0119" file="imgb0119.tif" wi="67" he="52" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0120" num="0120"><img id="ib0120" file="imgb0120.tif" wi="63" he="37" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0121" num="0121"><img id="ib0121" file="imgb0121.tif" wi="65" he="51" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0122" num="0122"><img id="ib0122" file="imgb0122.tif" wi="63" he="59" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="49"> -->
<chemistry id="chem0123" num="0123"><img id="ib0123" file="imgb0123.tif" wi="74" he="59" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0124" num="0124"><img id="ib0124" file="imgb0124.tif" wi="59" he="72" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0125" num="0125"><img id="ib0125" file="imgb0125.tif" wi="72" he="66" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="50"> -->
<chemistry id="chem0126" num="0126"><img id="ib0126" file="imgb0126.tif" wi="71" he="56" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0127" num="0127"><img id="ib0127" file="imgb0127.tif" wi="66" he="54" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0128" num="0128"><img id="ib0128" file="imgb0128.tif" wi="74" he="67" img-content="chem" img-format="tif"/></chemistry></p><p id="p0031" num="0031">The compound of Formula 1 may have a property that is required when<!-- EPO <DP n="51"> --> it is used as an organic material layer used in an organic light emitting device by using a core structure which is shown in Formula 1, that is, a structure in which arylene is substituted at a carbon position between R5 and R6 of carbazole as a core structure and introducing various substituents into the core structure including a structure that includes each independently hydrogen, heavy hydrogen; aliphatic hydrocarbon having 1-20 carbon atoms; aromatic hydrocarbon; aromatic hydrocarbon which is substituted with one or more substituent groups selected from the group consisting of nitro, nitrile, halogen, an alkyl group, an alkoxy group, an amino group, an aromatic hydrocarbon and a hetero ring group; a silicon group which is substituted with aromatic hydrocarbon; a hetero ring group; a hetero ring group which is substituted with one or more substituent groups selected from the group consisting of nitro, nitrile, halogen, an alkyl group, an alkoxy group, an amino group, an aromatic hydrocarbon and a hetero ring group; a thiophene group which is substituted with hydrocarbon having 1-20 carbon atoms or aromatic hydrocarbon having 6-20 carbon atoms; or a boron group which is substituted with an aromatic hydrocarbon.</p><p id="p0032" num="0032">The conjugation length of the compound has a close relationship with an energy band gap. In detail, the energy band gap is reduced as<!-- EPO <DP n="52"> --> the conjugation length of the compound increases. As described above, since a conjugation structure is limited in the core structure of the compound of Formula 1, the core structure has a large energy band gap.</p><p id="p0033" num="0033">As described above, in the present invention, various substituent groups are introduced to R1 to R7 and X and Y positions of the core structure having the large energy band gap so as to produce compounds having various energy band gaps. Generally, it is easy to control an energy band gap by introducing substituent groups into a core structure having a large energy band gap, but it is difficult to signifimaytly control the energy band gap by introducing substituent groups into a core structure having a small energy band gap. Furthermore, in the present invention, it is possible to control HOMO and LUMO energy levels of the compound by introducing various substituent groups into R1 to R7 and X and Y of the core structure.</p><p id="p0034" num="0034">Additionally, by introducing various substituent groups into the core structure, compounds having intrinsic characteristics of the substituent groups may be obtained. For example, substituent groups, which are frequently applied to hole injection layer material, hole transport layer material, light emitting layer material, and electron transport layer materials during the production of the organic light<!-- EPO <DP n="53"> --> emitting device, are introduced into the core structure so as to produce substances capable of satisfying the requirements of each organic material layer.</p><p id="p0035" num="0035">Since the core structure of the compound of Formula 1 includes the amine structure, it has an energy level suitable for the hole injection and/or hole transport materials in the organic light emitting device. In the present invention, the compound having the proper energy level is selected depending on the substituent group among the compounds represented by Formula 1 to be used in the organic light emitting device, thereby it is possible to realize a device having a low driving voltage and a high light efficiency.</p><p id="p0036" num="0036">Furthermore, various substituent groups are introduced into the core structure so as to precisely control the energy band gap, and to improve interfacial characteristics with organic materials, thereby apply the compound to various fields.</p><p id="p0037" num="0037">In addition, by controlling the number of amine that is included in the substitutent group B, HOMO and LUMO energy levels and the energy band gap are capable of being precisely controlled, and interfacial characteristics with organic materials are improved, thereby apply the compound to various fields.<!-- EPO <DP n="54"> --></p><p id="p0038" num="0038">Meanwhile, since the compound of Formula 1 has a high glass transition temperature (Tg), it has excellent thermal stability. Such increase in thermal stability is an important factor providing driving stability to the device.</p><p id="p0039" num="0039">Furthermore, the compound of Formula 1 may be used to form the organic material layer using a vacuum deposition process or a solution coat ing process during the product ion of the organic light emitting device. In connection with this, illustrative, but non-limiting, examples of the solution coating process include a spin coating process, a dip coating process, an inkjet printing process, a screen printing process, a spray process, and a roll coating process.</p><p id="p0040" num="0040">The organic light emitting device of the present invention may be produced using known materials through a known process, modified only in that at least one layer of organic material layer(s) include the compound of the present invention, that is, the compound of Formula 1.</p><p id="p0041" num="0041">The organic material layer(s) of the organic light emitting device according to the present invention may have a single layer structure, or alternatively, a multilayered structure in which at least two organic material layers are layered. For example, the organic light emitting device of the present invention may comprise a hole injection layer, a<!-- EPO <DP n="55"> --> hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer as the organic material layer(s). However, the structure of the organic light emitting device is not limited to this, but may comprise a smaller number of organic material layers.</p><p id="p0042" num="0042">Furthermore, the organic light emitting device of the present invention may be produced, for example, by sequentially layering a first electrode, organic material layer(s), and a second electrode on a substrate. In connection with this, a physical vapor deposition (PVD) method, such as a sputtering method or an e-beam evaporation method, may be used, but the method is not limited to these.</p><heading id="h0009">[Mode for Invention]</heading><p id="p0043" num="0043">A better understanding of a method of manufacturing an compound represented by Formula 1 may be obtained in light of the following Preparation Examples. However, the following Preparation Examples and Experimental Examples are set forth to illustrate, but are not to be construed to limit the present invention.</p><heading id="h0010">&lt;Preparation Example 1&gt; Manufacturing of the compound represented by Formula 4</heading><p id="p0044" num="0044"><!-- EPO <DP n="56"> --><chemistry id="chem0129" num="0129"><img id="ib0129" file="imgb0129.tif" wi="147" he="54" img-content="chem" img-format="tif"/></chemistry><chemistry id="chem0130" num="0130"><img id="ib0130" file="imgb0130.tif" wi="111" he="53" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0011">&lt;Preparation Example 1-1&gt; Manufacturing of the compound A</heading><p id="p0045" num="0045">After 2-bromothiopene (20 g, 122.7 mmol) and phenyl boronic acid (18 g, 147.6 mmol) were dissolved in tetrahydrofuran (300 ml), 4N potassium carbonate aqueous solution (130 mL) and tetrakis(triphenylphosphine)palladium (0) (2.9 g, 2.5 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the organic layer was separated and dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure, it was recrystallized by using hexane to obtain a compound A (14.6 g, yield<!-- EPO <DP n="57"> --> 74%; [M+H]<sup>+</sup> = 161).</p><heading id="h0012">&lt;Preparation Example 1-2&gt; Manufacturing of the compound B</heading><p id="p0046" num="0046">The compound A (18 g, 112.3 mmol) that was manufactured in Preparation Example 1-1 was dissolved in anhydrous tetrahydrofuran, n-butyl lithium (2.5M hexane solution, 49.4 mL, 123.5 mmol) was added dropwise at -78°C, and agitated for 1 hour. Trimethyl borate (15.1 g, 145.3 mmol) was put thereinto, agitated for 1 hour, 2N hydrochloric acid aqueous solution (80 mL) was put thereinto, and it was heated to normal temperature. After the organic layer was separated, it was dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure, it was recrystallized by using hexane to obtain a compound B (15.2 g, yield 66%; [M+H]<sup>+</sup> = 205).</p><heading id="h0013">&lt;Preparation Example 1-3&gt; Manufacturing of the compound C</heading><p id="p0047" num="0047">The compound B (15 g, 73.5 mmol) that was manufactured in Example 1-2 and 4-bromo-3-iodobenzene (20.8 g, 73.5 mmol) were dissolved in tetrahydrofuran (250 ml), 4N potassium carbonate aqueous solution (75 mL) and tetrakis(triphenylphosphine)palladium (0) (1.7 g, 1.5 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the organic layer was separated and dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure,<!-- EPO <DP n="58"> --> it was recrystallized by using ethanol to obtain a compound C (14.8 g, yield 64%; [M+H]<sup>+</sup> = 316).</p><heading id="h0014">&lt;Preparation Example 1-4&gt; Manufacturing of the compound D</heading><p id="p0048" num="0048">After the compound C (14 g, 44.4 mmol) that was manufactured in Preparation Example 1-3, carbazole (7.5 g, 44.9 mmol), sodium-tertiary-butoxide (5.5 g, 57.2 mmol) and bis (tri tertiary-butyl phosphine)palladium (0) (0.23 g, 0.45 mmol) were suspended in xylene (300 ml), they were refluxed while being agitated. After the reaction was finished, it was cooled to normal temperature, and the manufactured solid was filtered. It was sequentially washed by using water and ethanol to obtain a compound D (14.7 g, yield 82%; [M+H]<sup>+</sup> = 402)</p><heading id="h0015">&lt;Preparation Example 1-5&gt; Manufacturing of the compound E</heading><p id="p0049" num="0049">The compound D (14 g, 34.9 mmol) that was manufactured in Preparation Example 1-4 was dissolved in chloroform (300 mL), N-bromosuccinimide (6.3 g, 35.4 mmol) was added thereto, and they were agitated at normal temperature. After the reaction was finished, water was poured thereon, and the organic layer was separated, and it was dried by using anhydrous magnesium sulfate. It was distilled under the reduced pressure, and recrystallized by using tetrahydrofuran and ethanol to obtain a compound E (14.3 g, yield 85%; [M+H]<sup>+</sup> = 481)<!-- EPO <DP n="59"> --></p><heading id="h0016">&lt;Preparation Example 1-6&gt; Manufacturing of Formula 4</heading><p id="p0050" num="0050">The compound E (13 g, 27 mmol) that was manufactured in Example 1-5 and the compound B (5.5 g, 27 mmol) that was manufactured in Example 1-2 were dissolved in tetrahydrofuran (200 ml), 4N potassium carbonate aqueous solution (30 mL) and tetrakis(triphenylphosphine)palladium (0) (0.62 g, 0.54 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the organic layer was separated and dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure, it was recrystallized by using tetrahydrofuran and ethanol to obtain Formula 4 (10.7 g, yield 71%; [M+H]<sup>+</sup> = 560).</p><heading id="h0017">&lt;Preparation Example 2&gt; Manufacturing of the compound represented by Formula 5</heading><p id="p0051" num="0051"><chemistry id="chem0131" num="0131"><img id="ib0131" file="imgb0131.tif" wi="133" he="62" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0018">&lt;Preparation Example 2-1&gt; Manufacturing of the compound A</heading><p id="p0052" num="0052">After the compound E (10 g, 20.8 mmol) of Preparation Example 1-5,<!-- EPO <DP n="60"> --> and phenyl boronic acid (2.7 g, 22.1 mmol) were dissolved in tetrahydrofuran (300 ml), 4N potassium carbonate aqueous solution (25 mL) and tetrakis(triphenylphosphine)palladium (0) (0.49 g, 0.42 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the organic layer was separated and dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure, it was recrystallized by using tetrahydrofuran and hexane to obtain a compound A (8.2 g, yield 83%; [M+H]<sup>+</sup> = 478).</p><heading id="h0019">&lt;Preparation Example 2-2&gt; Manufacturing of the compound B</heading><p id="p0053" num="0053">The compound A (8 g, 16.7 mmol) that was manufactured in Preparation Example 2-1 was dissolved in chloroform (200 mL), N-bromosuccinimide (3 g, 16.9 mmol) was added thereto, and they were agitated at normal temperature. After the reaction was finished, water was poured thereon and the manufactured solid was filtered. It was sequentially washed by using water and ethanol to obtain a compound B (8.2 g, yield 88%; [M+H]<sup>+</sup> = 557).</p><heading id="h0020">&lt;Preparation Example 2-3&gt; Manufacturing of Formula 5</heading><p id="p0054" num="0054">The compound B (5 g, 9 mmol) that was manufactured in Preparation Example 2-2 and the compound B (1.9 g, 9.3 mmol) that was manufactured in Preparation Example 1-2 were dissolved in tetrahydrofuran (150 ml),<!-- EPO <DP n="61"> --> 4N potassium carbonate aqueous solution (12 mL) and tetrakis(triphenylphosphine)palladium (0) (0.2 g, 0.18 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the organic layer was separated and dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure, it was recrystallized by using tetrahydrofuran and ethanol to obtain Formula 5 (3.9 g, yield 68%; [M+H]<sup>+</sup> = 636).</p><heading id="h0021">&lt;Preparation Example 3&gt; Manufacturing of the compound represented by Formula 6</heading><p id="p0055" num="0055"><chemistry id="chem0132" num="0132"><img id="ib0132" file="imgb0132.tif" wi="121" he="52" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0022">&lt;Preparation Example 3-1&gt; Manufacturing of the compound A</heading><p id="p0056" num="0056">The compound C (10 g, 31.7 mmol) that was manufactured in Preparation Example 1-3 was dissolved in anhydrous tetrahydrofuran, n-butyl lithium (2.5M hexane solution, 13.8 mL, 34.5 mmol) was added dropwise at -78°C, and agitated for 1 hour. Trimethyl borate (4.3 g, 41.4 mmol) was put thereinto, agitated for 1 hour, 2N hydrochloric acid aqueous<!-- EPO <DP n="62"> --> solution (20 mL) was put thereinto, and it was heated to normal temperature. After the organic layer was separated, it was dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure, it was recrystallized by using hexane to obtain a compound A (5.4 g, yield 61%; [M+H]<sup>+</sup> = 281).</p><heading id="h0023">&lt;Preparation Example 3-2&gt; Manufacturing of Formula 6</heading><p id="p0057" num="0057">The compound A (5 g, 17.8 mmol) that was manufactured in Preparation Example 3-1 and the compound E (8.5 g, 17.7 mmol) that was manufactured in Preparation Example 1-5 were dissolved in tetrahydrofuran (150 ml), 4N potassium carbonate aqueous solution (20 mL) and tetrakis(triphenylphosphine)palladium (0) (0.42 g, 0.36 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the organic layer was separated and dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure, it was recrystallized by using tetrahydrofuran and ethanol to obtain Formula 6 (8.2 g, yield 73%; [M+H]+ = 636).</p><heading id="h0024">&lt;Preparation Example 4&gt; Manufacturing of the compound represented by Formula 7</heading><p id="p0058" num="0058"><chemistry id="chem0133" num="0133"><img id="ib0133" file="imgb0133.tif" wi="136" he="28" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="63"> --><chemistry id="chem0134" num="0134"><img id="ib0134" file="imgb0134.tif" wi="122" he="38" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0025">&lt;Preparation Example 4-1&gt; Manufacturing of the compound A</heading><p id="p0059" num="0059">The compound B (15 g, 73.5 mmol) that was manufactured in Preparation Example 1-2 and 3-bromo-1-iodobenzene (20.8 g, 73.5 mmol) were dissolved in tetrahydrofuran (180 ml), 4N potassium carbonate aqueous solution (75 mL) and tetrakis(triphenylphosphine)palladium (0) (1.7 g, 1.5 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the organic layer was separated and dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure, it was subjected to the column separation by using a tetrahydrofuran/hexane = 1/10 solvent to obtain a compound A (14.4 g, yield 62%; [M+H]<sup>+</sup> = 316).</p><heading id="h0026">&lt;Preparation Example 4-2&gt; Manufacturing of the compound B</heading><p id="p0060" num="0060">After the compound A (14 g, 44.4 mmol) that was manufactured in Preparation Example 4-1, carbazole (7.5 g, 44.9 mmol), sodium-tertiary-butoxide (5.5 g, 57.2 mmol) and bis (tri tertiary-butyl phosphine)palladium (0) (0.23 g, 0.45 mmol) were suspended in xylene (300<!-- EPO <DP n="64"> --> ml), they were refluxed while being agitated. After the reaction was finished, it was cooled to normal temperature, and the manufactured solid was filtered. It was sequentially washed by using water and ethanol to obtain a compound B (15.1 g, yield 85%; [M+H]<sup>+</sup> = 402).</p><heading id="h0027">&lt;Preparation Example 4-3&gt; Manufacturing of the compound C</heading><p id="p0061" num="0061">The compound B (15 g, 37.4 mmol) that was manufactured in Preparation Example 4-2 was dissolved in chloroform (300 mL), N-bromosuccinimide (6.7 g, 37.6 mmol) was added thereto, and they were agitated at normal temperature. After the reaction was finished, water was poured thereon, the organic layer was separated, and they were dried by using anhydrous magnesium sul fate. It was distilled under the reduced pressure and recrystallized by using tetrahydrofuran and ethanol to obtain a compound C (14.2 g, yield 79%; [M+H]<sup>+</sup> = 481).</p><heading id="h0028">&lt;Preparation Example 4-4&gt; Manufacturing of the compound D</heading><p id="p0062" num="0062">The compound C(13 g, 27 mmol) that was manufactured in Preparation Example 4-3 and 4-chlorophenyl borate (4.3 g, 27.5 mmol) were dissolved in tetrahydrofuran (300 ml), 4N potassium carbonate aqueous solution (33 mL) and tetrakis(triphenylphosphine)palladium (0) (0.62 g, 0.54 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the organic layer was separated and dried by using anhydrous<!-- EPO <DP n="65"> --> magnesium sulfate. After it was distilled under the reduced pressure, it was recrystallized by using tetrahydrofuran and ethanol to obtain a compound D (9.5g, yield 69%; [M+H]<sup>+</sup> = 512).</p><heading id="h0029">&lt;Preparation Example 4-5&gt; Manufacturing of Formula 7</heading><p id="p0063" num="0063">After the compound D (8 g, 15.6 mmol) that was manufactured in Preparation Example 4-4, N-phenyl-1-naphthyl amine (3.8 g, 17.3 mmol), sodium-tertiary-butoxide (2 g, 20.8 mmol) and bis (tri tertiary-butyl phosphine)palladium (0) (0.08 g, 0.16 mmol) were suspended in xylene (300 ml), they were refluxed while being agitated. After the reaction was finished, it was cooled to normal temperature, an acidic white clay was put thereinto, and they were agitated. After it was filtered, it was distilled under the reduced pressure, and subjected to the column separation by using a tetrahydrofuran/hexane = 1/7 solvent to obtain Formula 7 (6.4 g, yield 59%; [M+H]<sup>+</sup> = 695).</p><heading id="h0030">&lt;Preparation Example 5&gt; Manufacturing of the compound represented by Formula 8</heading><p id="p0064" num="0064"><chemistry id="chem0135" num="0135"><img id="ib0135" file="imgb0135.tif" wi="67" he="45" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="66"> --></p><heading id="h0031">&lt;Preparation Example 5-1&gt; Manufacturing of Formula 8</heading><p id="p0065" num="0065">After the compound D (8 g, 15.6 mmol) that was manufactured in Preparation Example 4-4, bis(4-biphenylyl)amine(5.5 g, 17.1 mmol), sodium-tertiary-butoxide (2 g, 20.8 mmol) and bis (tri tertiary-butyl phosphine)palladium (0) (0.08 g, 0.16 mmol) were suspended in xylene (250 ml), they were refluxed while being agitated. After the reaction was finished, it was cooled to normal temperature, an acidic white clay was put thereinto, and they were agitated. After it was filtered, it was distilled under the reduced pressure, and recrystallized by using tetrahydrofuran and ethanol to obtain Formula 8 (7.8 g, yield 63%; [M+H]<sup>+</sup> = 797).</p><heading id="h0032">&lt;Preparation Example 6&gt; Manufacturing of the compound represented by Formula 9</heading><p id="p0066" num="0066"><chemistry id="chem0136" num="0136"><img id="ib0136" file="imgb0136.tif" wi="118" he="58" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0033">&lt;Preparation Example 6-1&gt; Manufacturing of the compound A</heading><!-- EPO <DP n="67"> --><p id="p0067" num="0067">The compound E (10 g, 20.8 mmol) that was manufactured in Preparation Example 1-5 and 4-chlorophenyl borate (3.6 g, 23 mmol) were dissolved in tetrahydrofuran (250 ml), 4N potassium carbonate aqueous solution (22 mL) and tetrakis(triphenylphosphine)palladium (0) (0.49 g, 0.42 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the organic layer was separated and dried by using anhydrous magnesium sulfate. After it was distilled under the reduced pressure, it was recrystallized by using tetrahydrofuran and ethanol to obtain a compound A (7 g, yield 66%; [M+H]<sup>+</sup> = 512).</p><heading id="h0034">&lt;Preparation Example 6-2&gt; Manufacturing of Formula 9</heading><p id="p0068" num="0068">After the compound A (5 g, 9.7 mmol) that was manufactured in Preparation Example 6-1, bis(4-biphenylyl)amine (3.4 g, 10.6 mmol), sodium-tertiary-butoxide (1.2 g, 12.6 mmol) and bis (tri tertiary-butyl phosphine)palladium (0) (0.05 g, 0.1 mmol) were suspended in xylene (150 ml), they were refluxed while being agitated. After the reaction was finished, it was cooled to normal temperature, and the manufactured solide was filtered. After the filtered solide was dissolved in chloroform, an acidic white clay was put thereinto, and they were agitated. After it was filtered, it was distilled under the reduced pressure, and recrystallized by using tetrahydrofuran and ethanol to obtain Formula 9<!-- EPO <DP n="68"> --> (5.2 g, yield 67%; [M+H]<sup>+</sup> = 797).</p><heading id="h0035">&lt;Preparation Example 7&gt; Manufacturing of the compound represented by Formula 10</heading><p id="p0069" num="0069"><chemistry id="chem0137" num="0137"><img id="ib0137" file="imgb0137.tif" wi="151" he="64" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0036">&lt;Preparation Example 7-1&gt; Manufacturing of the compound A</heading><p id="p0070" num="0070">The compound D (10 g, 19.5 mmol) that was manufactured in Preparation Example 4-4 was dissolved in chloroform (300 mL), N-bromosuccinimide (3.7 g, 20.8 mmol) was added thereto, and they were agitated at normal temperature. After the reaction was finished, water was poured thereon, the organic layer was separated, and they were dried by using anhydrous magnesium sulfate. It was distilled under the reduced pressure and recrystallized by using tetrahydrofuran and ethanol to obtain a compound A (8.9 g, yield 77%; [M+H]<sup>+</sup> = 591).</p><heading id="h0037">&lt;Preparation Example 7-2&gt; Manufacturing of the compound B</heading><p id="p0071" num="0071">The compound A (8 g, 13.5 mmol) that was manufactured in Preparat ion<!-- EPO <DP n="69"> --> Example 7-1 and 4-chlorophenyl borate (2.3 g, 14.7 mmol) were dissolved in tetrahydrofuran (200 ml), 4N potassium carbonate aqueous solution (15 mL) and tetrakis(triphenylphosphine)palladium (0) (0.31 g, 0.27 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the manufactured solid was filtered. The filtered solid was recrysallized by using tetrahydrofuran and ethanol to obtain a compound B (5.2 g, yield 65%; [M+H]<sup>+</sup> = 588).</p><heading id="h0038">&lt;Preparation Example 7-3&gt; Manufacturing of Formula 10</heading><p id="p0072" num="0072">After the compound B (5 g, 8.5 mmol) that was manufactured in Preparation Example 7-2, bis(4-biphenylyl)amine (3 g, 9.3 mmol), sodium-tertiary-butoxide (1.1 g, 11.4 mmol) and bis (tri tertiary-butyl phosphine)palladium (0) (0.05 g, 0.1 mmol) were suspended in xylene (150 ml), they were refluxed while being agitated. After the reaction was finished, it was cooled to normal temperature, an acidic white clay was put thereinto, and they were agitated. After it was filtered, it was distilled under the reduced pressure, and recrystallized by using tetrahydrofuran and ethanol to obtain Formula 10 (4.5 g, yield 61%; [M+H]<sup>+</sup> = 873).</p><heading id="h0039">&lt;Preparation Example 8&gt; Manufacturing of the compound represented by Formula 11</heading><!-- EPO <DP n="70"> --><p id="p0073" num="0073"><chemistry id="chem0138" num="0138"><img id="ib0138" file="imgb0138.tif" wi="134" he="73" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0040">&lt;Preparation Example 8-1&gt; Manufacturing of the compound A</heading><p id="p0074" num="0074">The compound A (10 g, 19.5 mmol) that was manufactured in Preparation Example 6-1 was dissolved in chloroform (300 mL), N-bromosuccinimide (3.7 g, 20.8 mmol) was added thereto, and they were agitated at normal temperature. After the reaction was finished, water was poured thereon, the organic layer was separated, and they were dried by using anhydrous magnesium sulfate. It was distilled under the reduced pressure and recrystallized by using tetrahydrofuran and ethanol to obtain a compound A (9.4 g, yield 82%; [M+H]<sup>+</sup> = 591).</p><heading id="h0041">&lt;Preparation Example 8-2&gt; Manufacturing of the compound B</heading><p id="p0075" num="0075">The compound A (8 g, 13.5 mmol) that was manufactured in Preparation Example 8-1 and the compound B (3 g, 14.7 mmol) that was manufactured in Preparation Example 1-2 were dissolved in tetrahydrofuran (150 ml), 4N<!-- EPO <DP n="71"> --> potassium carbonate aqueous solution (15 mL) and tetrakis(triphenylphosphine)palladium (0) (0.31 g, 0.27 mmol) and were put thereinto and heated while being agitated. After the reaction was finished, the manufactured solid was filtered. The filtered solid was recrysallized by using tetrahydrofuran and ethanol to obtain a compound B (6.2 g, yield 69%; [M+H]<sup>+</sup> = 670).</p><heading id="h0042">&lt;Preparation Example 8-3&gt; Manufacturing of Formula 11</heading><p id="p0076" num="0076">After the compound B (6 g, 9 mmol) that was manufactured in Preparation Example 8-2, N-phenyl-1-naphthyl amine (2.1 g, 9.6 mmol), sodium-tertiary-butoxide (1.1 g, 11.7 mmol) and bis (tri tertiary-butyl phosphine)palladium (0) (0.05 g, 0.1 mmol) were suspended in xylene (100 ml), they were refluxed while being agitated. After the reaction was finished, it was cooled to normal temperature, an acidic white clay was put thereinto, and they were agitated. After it was filtered, it was distilled under the reduced pressure, and subjected to the column separation by using a tetrahydrofuran/hexane = 1/6 solvent to obtain Formula 11 (3.8 g, yield 49%; [M+H]<sup>+</sup> = 853).</p><heading id="h0043">&lt;Preparation Example 9&gt; Manufacturing of the compound represented by Formula 12</heading><!-- EPO <DP n="72"> --><p id="p0077" num="0077"><chemistry id="chem0139" num="0139"><img id="ib0139" file="imgb0139.tif" wi="147" he="59" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0044">&lt;Preparation Example 9-1&gt; Manufacturing of the compound A</heading><p id="p0078" num="0078">The compound D (10 g, 19.5 mmol) that was manufactured in Preparation Example 4-4 was dissolved in chloroform (300 mL), N-bromosuccinimide (3.7 g, 20.8 mmol) was added thereto, and they were agitated at normal temperature. After the reaction was finished, water was poured thereon, the organic layer was separated, and they were dried by using anhydrous magnesium sulfate. It was distilled under the reduced pressure and recrystallized by using tetrahydrofuran and ethanol to obtain a compound A (9.1 g, yield 79%; [M+H]<sup>+</sup> = 591).</p><heading id="h0045">&lt;Preparation Example 9-2&gt; Manufacturing of the compound B</heading><p id="p0079" num="0079">The compound A (9 g, 15.2 mmol) that was manufactured in Preparation Example 9-1 and the compound B (3.4 g, 16.7 mmol) that was manufactured in Preparation Example 1-2 were dissolved in tetrahydrofuran (150 ml), 4N potassium carbonate aqueous solution (18 mL) and tetrakis(triphenylphosphine)palladium (0) (0.35 g, 0.3 mmol) and were put<!-- EPO <DP n="73"> --> thereinto and heated while being agitated. After the reaction was finished, the manufactured solid was filtered. The filtered solid was recrysallized by using tetrahydrofuran and ethanol to obtain a compound B (7.3 g, yield 72%; [M+H]<sup>+</sup> = 670).</p><heading id="h0046">&lt;Preparation Example 9-3&gt; Manufacturing of Formula 12</heading><p id="p0080" num="0080">After the compound B (6 g, 9 mmol) that was manufactured in Preparation Example 9-2, bis(4-biphenylyl)amine (3 g, 9.3 mmol), sodium-tertiary-butoxide (1.1 g, 11.4 mmol) and bis (tri tertiary-butyl phosphine)palladium (0) (0.05 g, 0.1 mmol) were suspended in xylene (150 ml), they were refluxed while being agitated. After the reaction was finished, it was cooled to normal temperature, and the manufactured solid was filtered. The filtered solid was dissolved in chloroform, an acidic white clay was put thereinto, and they were agitated and filtered. After it was distilled under the reduced pressure, and recrystallized by using tetrahydrofuran and ethanol to obtain Formula 12 (5.6 g, yield 65%; [M+H]<sup>+</sup> = 955).</p><heading id="h0047">&lt;Preparation Example 10&gt; Manufacturing of Formula 13</heading><!-- EPO <DP n="74"> --><p id="p0081" num="0081"><chemistry id="chem0140" num="0140"><img id="ib0140" file="imgb0140.tif" wi="119" he="63" img-content="chem" img-format="tif"/></chemistry></p><p id="p0082" num="0082">The compound A (4 g, 7.8 mmol) of the Preparation Example 6 and the amine compound (3.17 g, 8.2 mmol) were dissolved in 150 ml of xylene, sodium-tertiary-butoxide (1.9 g, 19.5 mmol), and 20 mg of Pd[P(t-Bu)<sub>3</sub>]<sub>2</sub> (0.06 mmol) were added, and refluxed for 5 hours under the nitrogen atmosphere.</p><p id="p0083" num="0083">Distilled water was put in the react ion solution, the react ion was finished, and the organic layer was extracted. It was subjected to the column separat ion by using a normal-hexane/tetrahydrofuran = 10/1 solvent, agitated in petroleum ether, and vacuum dried to obtain Formula 13 (3.4 g, yield 50%). MS: [M+H]<sup>+</sup> = 861</p><heading id="h0048">&lt;Preparation Example 11&gt; Manufacturing of Formula 14</heading><!-- EPO <DP n="75"> --><p id="p0084" num="0084"><chemistry id="chem0141" num="0141"><img id="ib0141" file="imgb0141.tif" wi="143" he="60" img-content="chem" img-format="tif"/></chemistry></p><heading id="h0049">(1) Manufacturing of Formula A</heading><p id="p0085" num="0085">Carbazole (17.5 g, 104.8 mmol) was dissolved in dimethylacet amide (100mL), and 4-chloroiodobenzene (25 g, 104.8mmol), Cu (13.3 g, 209.6mmol), K<sub>2</sub>CO<sub>3</sub> (43.5 g, 314.4 mmol) were put thereinto, and they were refluxed for 12 hours.</p><p id="p0086" num="0086">After the reaction solution was filtered, concentrated, and recrystallized by using EtOH to obtain Formula A (24.8g, yield 85%). MS: [M+H]<sup>+</sup> = 278</p><heading id="h0050">(2) Manufacturing of Formula B</heading><p id="p0087" num="0087">Formula A (24.8 g, 89.3 mmol) that was manufactured in step (1) was dissolved in chloroform (200 mL), N-bromosuccinic imide (15.9 g, 89.3 mmol) was added thereto, and they were agitated for 5 hours at normal temperature.</p><p id="p0088" num="0088">Distilled water was put thereinto the reaction solution, the<!-- EPO <DP n="76"> --> reaction was finished, and the organic layer was extracted. After the reaction solution was concentrated, the next reaction was performed without the purification process. MS: [M+H]<sup>+</sup> = 357</p><heading id="h0051">(3) Manufacturing of Formula C</heading><p id="p0089" num="0089">Formula B (31.7 g, 89 mmol) that was manufactured in step (2) and 4-chlorophenyl boronic acid (15.3 g, 97.9 mmol) were dissolved in THF (150 mL), and Pd(PPh<sub>3</sub>)<sub>4</sub> (2.1 g, 1.78 mmol) and the K<sub>2</sub>CO<sub>3</sub> /H<sub>2</sub>O aqueous solution (6 g/100 mL, 356 mmol) were put thereinto, and they were refluxed for 24 hours.</p><p id="p0090" num="0090">Distilled water was put thereinto the reaction solution, the reaction was finished, and the organic layer was extracted. After the react ion solution was concentrated and subjected to the column separation by using a normal-hexane/tetrahydrofuran = 10/1 solvent, they were agitated in EtOH, filtered, and vacuum dried to obtain Formula C (8.9 g, yield 26%). MS: [M+H]<sup>+</sup> = 388</p><heading id="h0052">(4) Manufacturing of Formula 14</heading><p id="p0091" num="0091">Formula C (4.9 g, 12.6 mmol) that was manufactured in step (3) and N-phenyl-1-naphthyl amine (6.9 g, 31.5 mmol) were dissolved in 150 ml of xylene, sodium-tertiary-butoxide (3 g, 31.5 mmol), bisdibenzylideneacetonepalladium (0) (0.28 g, 0.5 mmol), and 50 wt%<!-- EPO <DP n="77"> --> tri-tertiary-butylphosphine toluene solution (0.24ml, 0.5 mmol) were added thereto, and refluxed for 5 hours under the nitrogen atmosphere.</p><p id="p0092" num="0092">Distilled water was put in the reaction solution, the react ion was finished, and the organic layer was extracted. It was subjected to the column separation by using a normal-hexane/tetrahydrofuran = 10/1 solvent, agitated in EtOH, filtered, and vacuum dried to obtain Formula 14 (1.8 g, yield 19%). MS: [M+H]<sup>+</sup> = 754</p><heading id="h0053">&lt;Preparation Example 12&gt; Manufacturing of Formula 15</heading><p id="p0093" num="0093"><chemistry id="chem0142" num="0142"><img id="ib0142" file="imgb0142.tif" wi="129" he="59" img-content="chem" img-format="tif"/></chemistry></p><p id="p0094" num="0094">Formula C (4 g, 10.3 mmol) that was manufactured in step (3) of Preparation Example 11 and bisdiphenylamine (8.28 g, 25.8 mmol) were dissolved in 150 ml of xylene, sodium-tertiary-butoxide (2.47 g, 25.8 mmol), and Pd[P(t-Bu)<sub>3</sub>]<sub>2</sub> (0.2 g, 0.4 mmol) were added thereto, and ref luxed for 5 hours under the nitrogen atmosphere.</p><p id="p0095" num="0095">Distilled water was put in the reaction solution, the reaction was<!-- EPO <DP n="78"> --> finished, and the organic layer was extracted. It was subjected to the column separation by using a normal-hexane/tetrahydrofuran = 10/1 solvent, agitated in petroleum ether, and vacuum dried to obtain Formula 15 (6.9 g, yield 70%). MS: [M+H]<sup>+</sup> = 958</p><heading id="h0054">&lt;Experimental Example 1&gt;</heading><p id="p0096" num="0096">A glass substrate, on which ITO (indium tin oxide) was applied to a thickness of 1500 Å to form a thin film, was put in distilled water, in which a detergent was dissolved, and washed using ultrasonic waves. In connection with this, a product manufactured by Fischer Inc. was used as the detergent, and distilled water was produced by filtering twice using a filter manufactured by Millipore Inc. After ITO was washed for 30 min, ultrasonic washing was conducted twice using distilled water for 10 min. After the washing using distilled water was completed, ultrasonic washing was conducted using isopropyl alcohol, acetone, and methanol solvents, and drying was then conducted. Next, it was transported to a plasma washing machine. In addition, the substrate was washed using oxygen plasma 85 W for 5 min, and then transported to a vacuum evaporator.</p><p id="p0097" num="0097">Hexanitrile hexaazatriphenylene (hereinafter, referred to as "HAT") of the following Formula was vacuum deposited to a thickness of 500 Å by heating on a transparent ITO electrode, which was prepared<!-- EPO <DP n="79"> --> through the above procedure, so as to form a hole injection layer.
<chemistry id="chem0143" num="0143"><img id="ib0143" file="imgb0143.tif" wi="31" he="42" img-content="chem" img-format="tif"/></chemistry></p><p id="p0098" num="0098">The compound of Formula 4, which was prepared in Example 1, was vacuum deposited to a thickness of 400 Å by heating on the hole injection layer so as to form a hole transport layer.</p><p id="p0099" num="0099">Subsequently, on the hole transport layer, GH and GD as described below were vacuum deposited to a film thickness of 300 Å at a film thickness ratio of 20:1 so as to form a light emitting layer.
<chemistry id="chem0144" num="0144"><img id="ib0144" file="imgb0144.tif" wi="109" he="54" img-content="chem" img-format="tif"/></chemistry></p><p id="p0100" num="0100">On the light emitting layer, the electron transport material as described below was vacuum deposited to a thickness of 200 Å so as to form an electron injection layer and a electron transport layer.<!-- EPO <DP n="80"> --></p><heading id="h0055">[electron transport material]</heading><p id="p0101" num="0101"><chemistry id="chem0145" num="0145"><img id="ib0145" file="imgb0145.tif" wi="45" he="41" img-content="chem" img-format="tif"/></chemistry></p><p id="p0102" num="0102">Lithium fluoride (LiF) having a thickness of 12 Å and aluminum having a thickness of 2000 Å were sequentially deposited on the electron injection layer and the electron transport layer to form a cathode.</p><p id="p0103" num="0103">In the above procedure, the deposition speed of an organic material was maintained at 0.4 to 0.7 Å/sec, lithium fluoride and aluminum were deposited at speeds of 0.3 Å/sec and 2 Å/sec, respectively, on the cathode, and in the deposition, a vacuum was maintained at 2 X 10<sup>-7</sup> to 5 X 10<sup>-8</sup> torr.</p><p id="p0104" num="0104">A forward current density of 4.8 V was applied to the light emitting device manufactured in the above, and as a result, the green light in which the color coordinate was (0.32, 0.66) at a current density of 50 mA/cm<sup>2</sup> was observed at 26 cd/A, and a life span to the luminance of 90% was 180 hours.</p><heading id="h0056">&lt;Experimental Example 2&gt;</heading><p id="p0105" num="0105">The same process was performed to manufacture an organic EL device,<!-- EPO <DP n="81"> --> except that the compound of Formula 5 was used instead of the compound of Formula 4 in Experimental Example 1.</p><p id="p0106" num="0106">A forward current density of 4.7 V was applied to the light emitting device manufactured in the above, and as a result, the green light in which the color coordinate was (0.33, 0.64) at a current density of 50 mA/cm<sup>2</sup> was observed at 27 cd/A, and a life span to the luminance of 90% was 200 hours.</p><heading id="h0057">&lt;Experimental Example 3&gt;</heading><p id="p0107" num="0107">The same process was performed to manufacture an organic EL device, except that the compound of Formula 6 was used instead of the compound of Formula 4 in Experimental Example 1.</p><p id="p0108" num="0108">A forward current density of 4.8 V was applied to the light emitting device manufactured in the above, and as a result, the green light in which the color coordinate was (0.33, 0.65) at a current density of 50 mA/cm<sup>2</sup> was observed at 29 cd/A, and a life span to the luminance of 90% was 210 hours.</p><heading id="h0058">&lt;Experimental Example 4&gt;</heading><p id="p0109" num="0109">The same process was performed to manufacture an organic EL device, except that the compound of Formula 7 was used instead of the compound of Formula 4 in Experimental Example 1.<!-- EPO <DP n="82"> --></p><p id="p0110" num="0110">A forward current density of 4.6 V was applied to the light emitting device manufactured in the above, and as a result, the green light in which the color coordinate was (0.32, 0.65) at a current density of 50 mA/cm<sup>2</sup> was observed at 28 cd/A, and a life span to the luminance of 90% was 190 hours.</p><heading id="h0059">&lt;Experimental Example 5&gt;</heading><p id="p0111" num="0111">The same process was performed to manufacture an organic EL device, except that the compound of Formula 8 was used instead of the compound of Formula 4 in Experimental Example 1.</p><p id="p0112" num="0112">A forward current density of 4.7 V was applied to the light emitting device manufactured in the above, and as a result, the green light in which the color coordinate was (0.32, 0.64) at a current density of 50 mA/cm<sup>2</sup> was observed at 30 cd/A, and a life span to the luminance of 90% was 250 hours.</p><heading id="h0060">&lt;Experimental Example 6&gt;</heading><p id="p0113" num="0113">The same process was performed to manufacture an organic EL device, except that the compound of Formula 9 was used instead of the compound of Formula 4 in Experimental Example 1.</p><p id="p0114" num="0114">A forward current density of 4.6 V was applied to the light emitting device manufactured in the above, and as a result, the green light in which<!-- EPO <DP n="83"> --> the color coordinate was (0.31, 0.65) at a current density of 50 mA/cm<sup>2</sup> was observed at 29 cd/A, and a life span to the luminance of 90% was 240 hours.</p><heading id="h0061">&lt;Experimental Example 7&gt;</heading><p id="p0115" num="0115">The same process was performed to manufacture an organic EL device, except that the compound of Formula 10 was used instead of the compound of Formula 4 in Experimental Example 1.</p><p id="p0116" num="0116">A forward current density of 4.5 V was applied to the light emitting device manufactured in the above, and as a result, the green light in which the color coordinate was (0.32, 0.65) at a current density of 50 mA/cm<sup>2</sup> was observed at 31 cd/A, and a life span to the luminance of 90% was 270 hours.</p><heading id="h0062">&lt;Experimental Example 8&gt;</heading><p id="p0117" num="0117">The same process was performed to manufacture an organic EL device, except that the compound of Formula 11 was used instead of the compound of Formula 4 in Experimental Example 1.</p><p id="p0118" num="0118">A forward current density of 4.4 V was applied to the light emitting device manufactured in the above, and as a result, the green light in which the color coordinate was (0.32, 0.66) at a current density of 50 mA/cm<sup>2</sup> was observed at 31 cd/A, and a life span to the luminance of 90% was 270<!-- EPO <DP n="84"> --> hours.</p><heading id="h0063">&lt;Experimental Example 9&gt;</heading><p id="p0119" num="0119">The same process was performed to manufacture an organic EL device, except that the compound of Formula 12 was used instead of the compound of Formula 4 in Experimental Example 1.</p><p id="p0120" num="0120">A forward current density of 4.4 V was applied to the light emitting device manufactured in the above, and as a result, the green light in which the color coordinate was (0.33, 0.65) at a current density of 50 mA/cm<sup>2</sup> was observed at 32 cd/A, and a life span to the luminance of 90% was 280 hours.</p><heading id="h0064">&lt;Comparative Example 1&gt;</heading><p id="p0121" num="0121">The same process was performed to manufacture an organic EL device, except that 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (NPB) of the following Formula was used instead of the compound of Formula 4 in Experimental Example 1.
<chemistry id="chem0146" num="0146"><img id="ib0146" file="imgb0146.tif" wi="49" he="40" img-content="chem" img-format="tif"/></chemistry></p><p id="p0122" num="0122">A forward current density of 4.6 V was applied to the light emitting<!-- EPO <DP n="85"> --> device manufactured in the above, and as a result, the green light in which the color coordinate was (0.32, 0.64) at a current density of 50 mA/cm<sup>2</sup> was observed at 26 cd/A, and a life span to the luminance of 90% was 140 hours.</p><heading id="h0065">[Industiral Applicability]</heading><p id="p0123" num="0123">A compound according to the present invention is conf igured so that stability in respects to a hole and an electron is increased while properties of carbazole are not largely changed by introducing heavy hydrogen to carbazole. These compounds may be used as an organic material layer material, particularly, a hole injection material and/or a hole transport material in an organic light emitting device, and in the case of when it is used in the organic light emitting device, a driving voltage of the device may be reduced, light efficiency may be improved, and a life span property of the device may be improved because of thermal stability of the compound.</p></description><claims mxw-id="PCLM56984522" lang="DE" load-source="patent-office"><!-- EPO <DP n="127"> --><claim id="c-de-01-0001" num="0001"><claim-text>Verbindung der folgenden Formel 1, Formel 3, Formel 4 oder Formel 5:
<chemistry id="chem0205" num="0205"><img id="ib0205" file="imgb0205.tif" wi="133" he="65" img-content="chem" img-format="tif"/></chemistry>
worin X - (A) m- (B) n ist,<br/>
Ar eine Arylengruppe mit 6 bis 40 Kohlenstoffatomen ist, die unsubstituiert oder mit einem oder mehreren Substituenten substituiert, ausgewählt aus der Gruppe bestehend aus Nitro, Nitril, Halogen, Alkylgruppe, Alkoxygruppe und Aminogruppe, oder eine bivalente Heteroringgruppe ist, die unsubstituiert oder substituiert ist mit einer oder mehreren<br/>
Substituentengruppen, ausgewählt aus der Gruppe bestehend aus Nitro, Nitril, Halogen, Alkylgruppe, Alkoxygruppe und Aminogruppe;<br/>
Ar' jeweils unabhängig ausgewählt ist aus der Gruppe bestehend aus einer Phenylgruppe, Biphenylgruppe, Terphenylgruppe, Stilbengruppe, Naphthylgruppe, Anthracenylgruppe, Phenanthrengruppe, Pyrenylgruppe und Perylenylgruppe,<br/>
<!-- EPO <DP n="128"> -->A eine Arylgruppe ist, die unsubstituiert oder substituiert mit einer oder mehreren<br/>
Substituentengruppen ist, ausgewählt aus der Gruppe bestehend aus einem Halogenatom, Alkylgruppe, Alkenylgruppe, Alkoxygruppe, substituierten oder unsubstituierten Arylamingruppe, substituierten oder unsubstituierten Arylgruppe, substituierten oder unsubstituierten Arylalkylgruppe, substituierten oder unsubstituierten Arylalkenylgruppe, substituierten oder unsubstituierten Heteroringgruppe, Nitrilgruppe und Acetylengruppe,<br/>
B eine Heteroringgruppe ist, umfassend O oder S als Heteroatom, die unsubstituiert oder substituiert ist mit einer oder mehreren Substituentengruppen, ausgewählt aus der Gruppe bestehend aus einem Halogenatom, einer Alkylgruppe, Alkenylgruppe, Alkoxygruppe, substituierten oder unsubstituierten Arylamingruppe, substituierten oder unsubstituierten Arylgruppe, substituierten oder unsubstituierten Arylalkylgruppe, substituierten oder unsubstituierten Arylalkenylgruppe, substituierten oder unsubstituierten Heteroringgruppe, Nitrilgruppe und Acetylengruppe,<br/>
m und n eine ganze Zahl im Bereich von 1 bis 10 jeweils sind,<br/>
Y eine Arylamingruppe ist, die unsubstituiert oder substituiert ist mit einer oder mehreren Substituentengruppen, ausgewählt aus der Gruppe bestehend aus einer Halogengruppe, Alkylgruppe, Alkenylgruppe, Alkoxygruppe, substituierten oder unsubstituierten Arylamingruppe, substituierten oder unsubstituierten Arylgruppe, substituierten oder unsubstituierten Arylalkylgruppe, substituierten oder unsubstituierten Arylalkenylgruppe, substituierten oder unsubstituierten Heteroringgruppe, Nitrilgruppe und Acetylengruppe; oder eine Heteroringgruppe, umfassend O, N oder S als Heteroatom, die unsubstituiert oder substituiert ist mit einer oder mehreren<!-- EPO <DP n="129"> --> Substituentengruppen, ausgewählt aus der Gruppe bestehend aus einer Halogengruppe, Alkylgruppe, Alkenylgruppe, Alkoxygruppe, substituierten oder unsubstituierten Arylamingruppe, substituierten oder unsubstituierten Arylgruppe, substituierten oder unsubstituierten Arylalkylgruppe, substituierten oder unsubstituierten Arylalkenylgruppe, substituierten oder unsubstituierten Heteroringgruppe, Nitrilgruppe und Acetylengruppe; und<br/>
R1 bis R8 jeweils unabhängig ausgewählt sind aus der Gruppe bestehend aus Wasserstoff, Alkylgruppe, die unsubstituiert oder substituiert ist mit einer oder mehreren Substituentengruppen, ausgewählt aus der Gruppe bestehend aus einer Halogengruppe, Alkylgruppe, Alkenylgruppe, Alkoxygruppe, substituierten oder unsubstituierten Arylalkylgruppe, substituierten oder unsubstituierten Arylalkenylgruppe, substituierten oder unsubstituierten Heteroringgruppe, Nitrilgruppe und Acetylengruppe; Alkoxygruppe, die unsubstituiert oder substituiert ist mit einer oder mehreren Substituentengruppen, ausgewählt aus der Gruppe bestehend aus einer Halogengruppe, Alkylgruppe, Alkenylgruppe, Alkoxygruppe, substituierten oder unsubstituierten Arylgruppe, substituierten oder unsubstituierten Arylalkylgruppe, substituierten oder unsubstituierten Arylalkenylgruppe, substituierten oder unsubstituierten Heteroringgruppe, Nitrilgruppe und Acetylengruppe; Arylgruppe, die unsubstituiert oder substituiert ist mit einer oder mehreren Substituentengruppen, ausgewählt aus der Gruppe bestehend aus einer Halogengruppe, Alkylgruppe, Alkenylgruppe, Alkoxygruppe, substituierten oder unsubstituierten Arylgruppe, substituierten oder unsubstituierten Arylalkylgruppe, substituierten oder unsubstituierten Arylalkenylgruppe, substituierten oder unsubstituierten Heteroringgruppe, Nitrilgruppe und Acetylengruppe; einer Aminogruppe, die unsubstituiert<!-- EPO <DP n="130"> --> ist oder mit einer oder mehreren Substituentengruppen substituiert ist, ausgewählt aus der Gruppe bestehend aus einer Alkylgruppe, Alkenylgruppe, substituierten oder unsubstituierten Arylgruppe, substituierten oder unsubstituierten Arylalkylgruppe, substituierten oder unsubstituierten Arylalkenylgruppe; Nitrogruppe; und einer Halogengruppe und worin R1 bis R8 einen aliphatischen oder Hetero-Kondensationsring im Zusammenhang mit benachbarten Gruppen bilden können,
<chemistry id="chem0206" num="0206"><img id="ib0206" file="imgb0206.tif" wi="128" he="68" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0207" num="0207"><img id="ib0207" file="imgb0207.tif" wi="128" he="80" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-de-01-0002" num="0002"><claim-text>Verbindung nach Anspruch 1, worin A der Formel 1 ausgewählt ist aus der Gruppe bestehend aus einer<!-- EPO <DP n="131"> --> Phenylgruppe, Biphenylgruppe, Terphenylgrupppe, Stilbengruppe, Naphthylgruppe, Anthracenylgruppe, Pheanthrengruppe, Pyrenylgruppe und Perylenylgruppe.</claim-text></claim><claim id="c-de-01-0003" num="0003"><claim-text>Verbindung nach Anspruch 1, worin B der Formel 1 ein Heteroring ist, ausgewählt aus der Gruppe bestehend aus einer Tiophengruppe und Furangruppe; und<br/>
Y der Formel 1 ein Heteroring ist und ausgewählt ist aus der Gruppe bestehend aus einer Thiophengruppe, Furangruppe, Pyrrolylgruppe, Imidazolylgruppe, Thiazolylgruppe, Oxazolylgruppe, Oxydiazolylgruppe, Triazolylgruppe, Pyridylgruppe, Chinolinylgruppe, Isochinolingruppe und Acridylgruppe.</claim-text></claim><claim id="c-de-01-0004" num="0004"><claim-text>Verbindung nach Anspruch 1, worin die Verbindung der Formel 1 dargestellt ist durch die folgende Formel 2:
<chemistry id="chem0208" num="0208"><img id="ib0208" file="imgb0208.tif" wi="66" he="72" img-content="chem" img-format="tif"/></chemistry>
worin Ar' ausgewählt ist aus der Gruppe bestehend aus einer Phenylgruppe, Biphenylgruppe, Terphenylgruppe, Stilbengruppe, Naphthylgruppe, Antracenylgruppe, Phenanthrengruppe, Pyrenylgruppe, Perylenylgruppe und Ar, Y und R1 bis R8 gleich sind wie die Definition in Bezug auf Ar, Y, und R1 bis R8 der Formeln 1 und 3.<!-- EPO <DP n="132"> --></claim-text></claim><claim id="c-de-01-0005" num="0005"><claim-text>Verbindung nach Anspruch 1, worin die Verbindung der Formel 1 dargestellt ist durch die folgende Formel 2-1 und die Verbindung der Formel 3 dargestellt ist durch die folgende Formel 3-1:
<chemistry id="chem0209" num="0209"><img id="ib0209" file="imgb0209.tif" wi="146" he="80" img-content="chem" img-format="tif"/></chemistry>
worin Ar, Y und R1 bis R8 gleich wie die Definition in Bezug auf Ar, Y und R1 bis R8 der Formeln 1 und 3 sind.</claim-text></claim><claim id="c-de-01-0006" num="0006"><claim-text>Verbindung nach Anspruch 1, worin die Verbindung der Formel 1 dargestellt ist durch die folgende Formel 2-2 und die Verbindung der Formel 3 dargestellt ist durch die folgende Formel 3-2:
<chemistry id="chem0210" num="0210"><img id="ib0210" file="imgb0210.tif" wi="145" he="71" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="133"> -->
worin Ar, Y und R1 bis R8 gleich wie die Definition in Bezug auf Ar, Y und R1 bis R8 der Formeln 1 und 3 sind.</claim-text></claim><claim id="c-de-01-0007" num="0007"><claim-text>Verbindung nach Anspruch 1, worin dann, wenn Y der Formeln 1 oder 3 Arylamin ist, diese eine der folgenden Gruppen darstellt:
<chemistry id="chem0211" num="0211"><img id="ib0211" file="imgb0211.tif" wi="165" he="172" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="134"> -->
<chemistry id="chem0212" num="0212"><img id="ib0212" file="imgb0212.tif" wi="165" he="199" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="135"> -->
<chemistry id="chem0213" num="0213"><img id="ib0213" file="imgb0213.tif" wi="165" he="184" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="136"> -->
<chemistry id="chem0214" num="0214"><img id="ib0214" file="imgb0214.tif" wi="165" he="198" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="137"> -->
<chemistry id="chem0215" num="0215"><img id="ib0215" file="imgb0215.tif" wi="165" he="206" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="138"> -->
<chemistry id="chem0216" num="0216"><img id="ib0216" file="imgb0216.tif" wi="165" he="214" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="139"> -->
<chemistry id="chem0217" num="0217"><img id="ib0217" file="imgb0217.tif" wi="165" he="214" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="140"> -->
<chemistry id="chem0218" num="0218"><img id="ib0218" file="imgb0218.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="141"> -->
<chemistry id="chem0219" num="0219"><img id="ib0219" file="imgb0219.tif" wi="165" he="221" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="142"> -->
<chemistry id="chem0220" num="0220"><img id="ib0220" file="imgb0220.tif" wi="165" he="221" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="143"> -->
<chemistry id="chem0221" num="0221"><img id="ib0221" file="imgb0221.tif" wi="165" he="215" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="144"> -->
<chemistry id="chem0222" num="0222"><img id="ib0222" file="imgb0222.tif" wi="165" he="215" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="145"> -->
<chemistry id="chem0223" num="0223"><img id="ib0223" file="imgb0223.tif" wi="165" he="211" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="146"> -->
<chemistry id="chem0224" num="0224"><img id="ib0224" file="imgb0224.tif" wi="165" he="186" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="147"> -->
<chemistry id="chem0225" num="0225"><img id="ib0225" file="imgb0225.tif" wi="165" he="184" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="148"> -->
<chemistry id="chem0226" num="0226"><img id="ib0226" file="imgb0226.tif" wi="165" he="189" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="149"> -->
<chemistry id="chem0227" num="0227"><img id="ib0227" file="imgb0227.tif" wi="165" he="189" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="150"> -->
<chemistry id="chem0228" num="0228"><img id="ib0228" file="imgb0228.tif" wi="165" he="189" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="151"> -->
<chemistry id="chem0229" num="0229"><img id="ib0229" file="imgb0229.tif" wi="165" he="204" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="152"> -->
<chemistry id="chem0230" num="0230"><img id="ib0230" file="imgb0230.tif" wi="165" he="214" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="153"> -->
<chemistry id="chem0231" num="0231"><img id="ib0231" file="imgb0231.tif" wi="165" he="214" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="154"> -->
<chemistry id="chem0232" num="0232"><img id="ib0232" file="imgb0232.tif" wi="165" he="189" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="155"> -->
<chemistry id="chem0233" num="0233"><img id="ib0233" file="imgb0233.tif" wi="165" he="189" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="156"> -->
<chemistry id="chem0234" num="0234"><img id="ib0234" file="imgb0234.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="157"> -->
<chemistry id="chem0235" num="0235"><img id="ib0235" file="imgb0235.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="158"> -->
<chemistry id="chem0236" num="0236"><img id="ib0236" file="imgb0236.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="159"> -->
<chemistry id="chem0237" num="0237"><img id="ib0237" file="imgb0237.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="160"> -->
<chemistry id="chem0238" num="0238"><img id="ib0238" file="imgb0238.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="161"> -->
<chemistry id="chem0239" num="0239"><img id="ib0239" file="imgb0239.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="162"> -->
<chemistry id="chem0240" num="0240"><img id="ib0240" file="imgb0240.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="163"> -->
<chemistry id="chem0241" num="0241"><img id="ib0241" file="imgb0241.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="164"> -->
<chemistry id="chem0242" num="0242"><img id="ib0242" file="imgb0242.tif" wi="165" he="131" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-de-01-0008" num="0008"><claim-text>Verbindung nach Anspruch 1, worin Ar der Formel 1 oder 3 Phenylen ist.</claim-text></claim><claim id="c-de-01-0009" num="0009"><claim-text>Verbindung nach Anspruch 1, worin die Verbindung der Formel 1 oder 3 eine Verbindung der folgenden Formeln 6 bis 13 ist:
<chemistry id="chem0243" num="0243"><img id="ib0243" file="imgb0243.tif" wi="97" he="56" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="165"> -->
<chemistry id="chem0244" num="0244"><img id="ib0244" file="imgb0244.tif" wi="105" he="54" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0245" num="0245"><img id="ib0245" file="imgb0245.tif" wi="105" he="69" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0246" num="0246"><img id="ib0246" file="imgb0246.tif" wi="105" he="80" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="166"> -->
<chemistry id="chem0247" num="0247"><img id="ib0247" file="imgb0247.tif" wi="103" he="75" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0248" num="0248"><img id="ib0248" file="imgb0248.tif" wi="103" he="88" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0249" num="0249"><img id="ib0249" file="imgb0249.tif" wi="103" he="76" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="167"> -->
<chemistry id="chem0250" num="0250"><img id="ib0250" file="imgb0250.tif" wi="86" he="64" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-de-01-0010" num="0010"><claim-text>Organische Licht-emittierende Vorrichtung, die eine erste Elektrode, eine organische Materialschicht, die eine oder mehrere Schichten mit einer Lichtemittierenden Schicht umfasst, und eine zweite Elektrode enthält, die aufeinanderfolgend geschichtet sind,<br/>
worin die organische Licht-emittierende Vorrichtung eine oder mehrere Schichten aus der organischen Materialschicht enthält, die eine Lochtransportschicht, eine Lochinjektionsschicht, eine Lochtransport- und -injektionsschicht oder eine Elektroneninjektions- und -transportschicht umfasst, und<br/>
die Lochtransportschicht, die<br/>
Lochinjektionsschicht, die Lochtransport- und -injektionsschicht, die Elektroneninjektions- und -transportschicht oder die Licht-emittierende Schicht die Verbindung der Formeln 1, 3, 4 oder 5, wie in Anspruch 1 definiert enthält.</claim-text></claim></claims><claims mxw-id="PCLM56984523" lang="EN" load-source="patent-office"><!-- EPO <DP n="86"> --><claim id="c-en-01-0001" num="0001"><claim-text>A compound of the following Formula 1, Formula 3, Formula 4 or Formula 5:
<chemistry id="chem0147" num="0147"><img id="ib0147" file="imgb0147.tif" wi="126" he="70" img-content="chem" img-format="tif"/></chemistry>
wherein x is -(A)m-(B)n,<br/>
Ar is an arylene group having 6 to 40 carbon atoms, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of nitro, nitrile, halogen, an alkyl group, an alkoxy group and an amino group, or a divalent hetero ring group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of nitro, nitrile, halogen, an alkyl group, an alkoxy group and an amino group;<br/>
Ar' is each independently selected from the group consisting of a phenyl group, a biphenyl group, a terphenyl group, a stilbene group, a naphthyl group, an anthracenyl group, a phenanthrene group, a pyrenyl group and a perylenyl group,<br/>
A is an aryl group, which is substituted or unsubstituted with one or more substituent groups<!-- EPO <DP n="87"> --> selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group,<br/>
B is a hetero ring group including O or S as a heteroatom, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group,<br/>
m and n are an integer in the range of 1 to 10, respectively,<br/>
Y is an arylamine group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group; or a hetero ring group including O , N or S as a heteroatom, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or<!-- EPO <DP n="88"> --> unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group, and<br/>
R1 to R8 are each independently selected from the group consisting of hydrogen; an alkyl group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group; an alkoxy group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group; an aryl group, which is substituted or unsubstituted with one or more substituent groups selected from the group consisting of a halogen group, an alkyl group, an alkenyl group, an alkoxy group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylalkenyl group, a substituted or unsubstituted hetero ring group, a nitrile group and an acetylene group; an amino group, which is substituted with one or more substituent groups selected from the group consisting of an alkyl group, an alkenyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, and a substituted or unsubstituted arylalkenyl group; a nitro group; and a halogen group, and said R1 to R8 may form an aliphatic or hetero condensation ring in conjunction with adjacent groups,<!-- EPO <DP n="89"> -->
<chemistry id="chem0148" num="0148"><img id="ib0148" file="imgb0148.tif" wi="126" he="66" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0149" num="0149"><img id="ib0149" file="imgb0149.tif" wi="126" he="81" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-en-01-0002" num="0002"><claim-text>The compound as set forth in claim 1, wherein A of Formula 1 is selected from the group consisting of a phenyl group, a biphenyl group, a terphenyl group, a stilbene group, a naphthyl group, an anthracenyl group, a phenanthrene group, a pyrenyl group and a perylenyl group.</claim-text></claim><claim id="c-en-01-0003" num="0003"><claim-text>The compound as set forth in claim 1, wherein B of Formula 1 is a hetero ring, which is selected from the group consisting of a thiophene group and furan group;<br/>
and<br/>
<!-- EPO <DP n="90"> -->Y of Formula 1 is a hetero ring, it is selected from the group consisting of a thiophene group, a furan group, a pyrrolyl group, an imidazolyl group, a thiazolyl group, an oxazolyl group, an oxadiazolyl group, a triazolyl group, a pyridyl group, a quinolinyl group, an isoquinoline group, and an acridyl group.</claim-text></claim><claim id="c-en-01-0004" num="0004"><claim-text>The compound as set forth in claim 1, wherein the compound of Formula 1 is represented by the following Formula 2:
<chemistry id="chem0150" num="0150"><img id="ib0150" file="imgb0150.tif" wi="69" he="70" img-content="chem" img-format="tif"/></chemistry>
wherein Ar' is selected from the group consisting of a phenyl group, a biphenyl group, a terphenyl group, a stilbene group, a naphthyl group, an anthracenyl group, a phenanthrene group, a pyrenyl group, a perylenyl group, and Ar, Y and R1 to R8 are the same as the definitions in respect to Ar, Y and R1 to R8 of Formula 1 and Formula 3.</claim-text></claim><claim id="c-en-01-0005" num="0005"><claim-text>The compound as set forth in claim 1, wherein the compound of Formula 1 is represented by the following Formula 2-1 and the compound of Formula 3 is represented by the following Formula 3-1:<!-- EPO <DP n="91"> -->
<chemistry id="chem0151" num="0151"><img id="ib0151" file="imgb0151.tif" wi="136" he="81" img-content="chem" img-format="tif"/></chemistry>
wherein Ar, Y and R1 to R8 are the same as the definitions in respect to Ar, Y and R1 to R8 of Formula 1 and Formula 3.</claim-text></claim><claim id="c-en-01-0006" num="0006"><claim-text>The compound as set forth in claim 1, wherein the compound of Formula 1 is represented by the following Formula 2-2 and the compound of Formula 3 is represented by the following Formula 3-2:
<chemistry id="chem0152" num="0152"><img id="ib0152" file="imgb0152.tif" wi="136" he="69" img-content="chem" img-format="tif"/></chemistry>
wherein Ar, Y and R1 to R8 are the same as the definitions in respect to Ar, Y and R1 to R8 of Formula 1 or Formula 3.<!-- EPO <DP n="92"> --></claim-text></claim><claim id="c-en-01-0007" num="0007"><claim-text>The compound as set forth in claim 1, wherein when Y of Formula 1 or formula 3 is arylamine, it is any one of the following groups:
<chemistry id="chem0153" num="0153"><img id="ib0153" file="imgb0153.tif" wi="165" he="36" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0154" num="0154"><img id="ib0154" file="imgb0154.tif" wi="165" he="42" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0155" num="0155"><img id="ib0155" file="imgb0155.tif" wi="165" he="28" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0156" num="0156"><img id="ib0156" file="imgb0156.tif" wi="165" he="29" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0157" num="0157"><img id="ib0157" file="imgb0157.tif" wi="165" he="40" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="93"> -->
<chemistry id="chem0158" num="0158"><img id="ib0158" file="imgb0158.tif" wi="165" he="42" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0159" num="0159"><img id="ib0159" file="imgb0159.tif" wi="165" he="42" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0160" num="0160"><img id="ib0160" file="imgb0160.tif" wi="165" he="40" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0161" num="0161"><img id="ib0161" file="imgb0161.tif" wi="165" he="35" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0162" num="0162"><img id="ib0162" file="imgb0162.tif" wi="165" he="50" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="94"> -->
<chemistry id="chem0163" num="0163"><img id="ib0163" file="imgb0163.tif" wi="165" he="39" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0164" num="0164"><img id="ib0164" file="imgb0164.tif" wi="165" he="41" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0165" num="0165"><img id="ib0165" file="imgb0165.tif" wi="165" he="49" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0166" num="0166"><img id="ib0166" file="imgb0166.tif" wi="165" he="51" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="95"> -->
<chemistry id="chem0167" num="0167"><img id="ib0167" file="imgb0167.tif" wi="165" he="50" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0168" num="0168"><img id="ib0168" file="imgb0168.tif" wi="165" he="151" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="96"> -->
<chemistry id="chem0169" num="0169"><img id="ib0169" file="imgb0169.tif" wi="165" he="217" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="97"> -->
<chemistry id="chem0170" num="0170"><img id="ib0170" file="imgb0170.tif" wi="165" he="218" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="98"> -->
<chemistry id="chem0171" num="0171"><img id="ib0171" file="imgb0171.tif" wi="165" he="217" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="99"> -->
<chemistry id="chem0172" num="0172"><img id="ib0172" file="imgb0172.tif" wi="165" he="206" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="100"> -->
<chemistry id="chem0173" num="0173"><img id="ib0173" file="imgb0173.tif" wi="165" he="218" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="101"> -->
<chemistry id="chem0174" num="0174"><img id="ib0174" file="imgb0174.tif" wi="165" he="216" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="102"> -->
<chemistry id="chem0175" num="0175"><img id="ib0175" file="imgb0175.tif" wi="165" he="207" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="103"> -->
<chemistry id="chem0176" num="0176"><img id="ib0176" file="imgb0176.tif" wi="165" he="207" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="104"> -->
<chemistry id="chem0177" num="0177"><img id="ib0177" file="imgb0177.tif" wi="165" he="208" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="105"> -->
<chemistry id="chem0178" num="0178"><img id="ib0178" file="imgb0178.tif" wi="165" he="193" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="106"> -->
<chemistry id="chem0179" num="0179"><img id="ib0179" file="imgb0179.tif" wi="164" he="184" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="107"> -->
<chemistry id="chem0180" num="0180"><img id="ib0180" file="imgb0180.tif" wi="165" he="185" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="108"> -->
<chemistry id="chem0181" num="0181"><img id="ib0181" file="imgb0181.tif" wi="165" he="185" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="109"> -->
<chemistry id="chem0182" num="0182"><img id="ib0182" file="imgb0182.tif" wi="165" he="185" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="110"> -->
<chemistry id="chem0183" num="0183"><img id="ib0183" file="imgb0183.tif" wi="165" he="202" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="111"> -->
<chemistry id="chem0184" num="0184"><img id="ib0184" file="imgb0184.tif" wi="165" he="207" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="112"> -->
<chemistry id="chem0185" num="0185"><img id="ib0185" file="imgb0185.tif" wi="165" he="195" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="113"> -->
<chemistry id="chem0186" num="0186"><img id="ib0186" file="imgb0186.tif" wi="165" he="174" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="114"> -->
<chemistry id="chem0187" num="0187"><img id="ib0187" file="imgb0187.tif" wi="165" he="174" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="115"> -->
<chemistry id="chem0188" num="0188"><img id="ib0188" file="imgb0188.tif" wi="165" he="197" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="116"> -->
<chemistry id="chem0189" num="0189"><img id="ib0189" file="imgb0189.tif" wi="165" he="197" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="117"> -->
<chemistry id="chem0190" num="0190"><img id="ib0190" file="imgb0190.tif" wi="165" he="203" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="118"> -->
<chemistry id="chem0191" num="0191"><img id="ib0191" file="imgb0191.tif" wi="165" he="196" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="119"> -->
<chemistry id="chem0192" num="0192"><img id="ib0192" file="imgb0192.tif" wi="165" he="196" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="120"> -->
<chemistry id="chem0193" num="0193"><img id="ib0193" file="imgb0193.tif" wi="165" he="196" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="121"> -->
<chemistry id="chem0194" num="0194"><img id="ib0194" file="imgb0194.tif" wi="165" he="196" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="122"> -->
<chemistry id="chem0195" num="0195"><img id="ib0195" file="imgb0195.tif" wi="165" he="198" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="123"> -->
<chemistry id="chem0196" num="0196"><img id="ib0196" file="imgb0196.tif" wi="165" he="134" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-en-01-0008" num="0008"><claim-text>The compound as set forth in claim 1, wherein Ar of Formula 1 or Formula 3 is phenylene.</claim-text></claim><claim id="c-en-01-0009" num="0009"><claim-text>The compound as set forth in claim 1, wherein the compound of Formula 1 or Formula 3 is any one compound of the following Formula 6 to Formula 13:<!-- EPO <DP n="124"> -->
<chemistry id="chem0197" num="0197"><img id="ib0197" file="imgb0197.tif" wi="102" he="61" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0198" num="0198"><img id="ib0198" file="imgb0198.tif" wi="102" he="51" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0199" num="0199"><img id="ib0199" file="imgb0199.tif" wi="102" he="76" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="125"> -->
<chemistry id="chem0200" num="0200"><img id="ib0200" file="imgb0200.tif" wi="105" he="79" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0201" num="0201"><img id="ib0201" file="imgb0201.tif" wi="105" he="75" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0202" num="0202"><img id="ib0202" file="imgb0202.tif" wi="105" he="81" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="126"> -->
<chemistry id="chem0203" num="0203"><img id="ib0203" file="imgb0203.tif" wi="101" he="77" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0204" num="0204"><img id="ib0204" file="imgb0204.tif" wi="101" he="59" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-en-01-0010" num="0010"><claim-text>An organic light emitting device that includes a first electrode, an organic material layer that includes one or more layers having a light emitting layer, and a second electrode sequentially layered,<br/>
wherein the organic light emitting device comprises one or more layers of the organic material layer that includes a hole transport layer, a hole injection layer, a hole transport and injection layer, or an electron injection and transport layer, and<br/>
the hole transport layer, the hole injection layer, the hole transport and injection layer, the electron injection and transport layer, or the light emitting layer include the compound of Formula 1, Formula 3, Formula 4 or Formula 5 as defined in claim 1.</claim-text></claim></claims><claims mxw-id="PCLM56984524" lang="FR" load-source="patent-office"><!-- EPO <DP n="168"> --><claim id="c-fr-01-0001" num="0001"><claim-text>Composé de la Formule 1, de la Formule 3, de la Formule 4 ou de la Formule 5 suivante :
<chemistry id="chem0251" num="0251"><img id="ib0251" file="imgb0251.tif" wi="143" he="79" img-content="chem" img-format="tif"/></chemistry>
dans laquelle X est -(A)m-(B)n,<br/>
Ar est un groupe arylène ayant de 6 à 40 atomes de carbone, qui est substitué ou non substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un nitro, un nitrile, un halogène, un groupe alkyle, un groupe alcoxy et un groupe amino, ou un groupe hétérocyclique divalent, qui est substitué ou non substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un nitro, un nitrile, un halogène, un groupe alkyle, un groupe alcoxy et un groupe amino ;<br/>
Ar' est chacun indépendamment choidi dans le groupe constitué par un groupe phényle, un groupe biphényle, un groupe terphényle, un groupe stilbène, un groupe naphtyle, un groupe anthracényle, un groupe phénanthrène, un groupe pyrényle et un groupe pérylényle,<br/>
A est un groupe aryle, qui est substitué ou non substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un groupe halogène, un groupe alkyle, un groupe alcényle, un groupe alcoxy, un groupe arylamine substitué ou non substitué, un groupe aryle substitué ou non substitué, un groupe arylalkyle<!-- EPO <DP n="169"> --> substitué ou non substitué, un groupe arylalcényle substitué ou non substitué, un groupe hétérocyclique substitué ou non substitué, un groupe nitrile et un groupe acétylène,<br/>
B est un groupe hétérocyclique comprenant O ou S comme hétéroatome, qui est substitué ou non substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un groupe halogène, un groupe alkyle, un groupe alcényle, un groupe alcoxy, un groupe arylamine substitué ou non substitué, un groupe aryle substitué ou non substitué, un groupe arylalkyle substitué ou non substitué, un groupe arylalcényle substitué ou non substitué, un groupe hétéro cycle substitué ou non substitué, un groupe nitrile et un groupe acétylène,<br/>
m et n sont un nombre entier dans la plage de 1 à 10, respectivement,<br/>
Y est un groupe arylamine, qui est substitué ou non substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un groupe halogène, un groupe alkyle, un groupe alcényle, un groupe alcoxy, un groupe arylamine substitué ou non substitué, un groupe aryle substitué ou non substitué, un groupe arylalkyle substitué ou non substitué, un groupe arylalcényle substitué ou non substitué, un groupe hétérocyclique substitué ou non substitué, un groupe nitrile et un groupe acétylène; ou un groupe hétérocyclique comprenant O, N ou S comme hétéroatome, qui est substitué ou non substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un groupe halogène, un groupe alkyle, un groupe alcényle, un groupe alcoxy, un groupe arylamine substitué ou non substitué, un groupe aryle substitué ou non substitué, un groupe arylalkyle substitué ou non substitué, un groupe arylalcényle substitué ou non substitué, un groupe hétérocyclique substitué ou non substitué, un groupe nitrile et un groupe acétylène, et<br/>
R1 à R8 sont chacun indépendamment choisis dans le groupe constitué par un hydrogène; un groupe alkyle, qui est substitué ou non substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un groupe halogène, un groupe alkyle, un groupe alcényle, un groupe alcoxy, un groupe aryle substitué ou non substitué, un groupe arylalkyle substitué ou non substitué, un groupe arylalcényle substitué ou non substitué, un groupe hétérocyclique substitué ou non substitué, un groupe nitrile et un groupe acétylène; un groupe alcoxy, qui est<!-- EPO <DP n="170"> --> substitué ou non substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un groupe halogène, un groupe alkyle, un groupe alcényle, un groupe alcoxy, un groupe aryle substitué ou non substitué, un groupe arylalkyle substitué ou non substitué, un groupe arylalcényle substitué ou non substitué, un groupe hétérocyclique substitué ou non substitué, un groupe nitrile et un groupe acétylène; un groupe aryle, qui est substitué ou non substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un groupe halogène, un groupe alkyle, un groupe alcényle, un groupe alcoxy, un groupe aryle substitué ou non substitué, un groupe arylalkyle substitué ou non substitué, un groupe arylalcényle substitué ou non substitué, un groupe hétérocyclique substitué ou non substitué, un groupe nitrile et un groupe acétylène; un groupe amino, qui est substitué par un ou plusieurs groupes substituants choisis dans le groupe constitué par un groupe alkyle, un groupe alcényle, un groupe aryle substitué ou non substitué, un groupe arylalkyle substitué ou non substitué et un groupe arylalcényle substitué ou non substitué; un groupe nitro ; et un groupe halogène, et lesdits R1 à R8 peuvent former un cycle de condensation aliphatique ou hétéro conjointement en conjonction avec des groupes adjacents.
<chemistry id="chem0252" num="0252"><img id="ib0252" file="imgb0252.tif" wi="102" he="85" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="171"> -->
<chemistry id="chem0253" num="0253"><img id="ib0253" file="imgb0253.tif" wi="103" he="101" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-fr-01-0002" num="0002"><claim-text>Composé selon la revendication 1, dans lequel A de la Formule 1 est choisi dans le groupe constitué par un groupe phényle, un groupe biphényle, un groupe terphényle, un groupe stilbène, un groupe naphtyle, un groupe anthracényle, un groupe phénanthrène, un groupe pyrényle et un groupe pérylényle.</claim-text></claim><claim id="c-fr-01-0003" num="0003"><claim-text>Composé selon la revendication 1, dans lequel B de la Formule 1 est un hétérocycle, qui est choisi dans le groupe constitué par un groupe thiophène et un groupe furane; et<br/>
Y de la Formule 1 est un hétérocycle, il est choisi dans le groupe constitué par un groupe thiophène, un groupe furane, un groupe pyrrolyle, un groupe imidazolyle, un groupe thiazolyle, un groupe oxazolyle, un groupe oxadiazolyle, un groupe triazolyle, un groupe pyridyle, un groupe quinolinyle, un groupe isoquinoline et un groupe acridyle.</claim-text></claim><claim id="c-fr-01-0004" num="0004"><claim-text>Composé selon la revendication 1, dans lequel le composé de Formule 1 est représenté par la Formule 2 suivante :<!-- EPO <DP n="172"> -->
<chemistry id="chem0254" num="0254"><img id="ib0254" file="imgb0254.tif" wi="77" he="76" img-content="chem" img-format="tif"/></chemistry>
dans laquelle Ar' est choisi dans le groupe constitué par un groupe phényle, un groupe biphényle, un groupe terphényle, un groupe stilbène, un groupe naphtyle, un groupe anthacényle, un groupe phénanthrène, un groupe pyrényle, un groupe pérylényle, et Ar, Y et R1 à R8 sont identiques aux définitions concernant Ar, Y et R1 à R8 de la Formule 1 et de la Formule 3.</claim-text></claim><claim id="c-fr-01-0005" num="0005"><claim-text>Composé selon la revendication 1, dans lequel le composé de la Formule 1 est représenté par la Formule 2-1 suivante et le composé de Formule 3 est représenté par la Formule 3-1 suivante :
<chemistry id="chem0255" num="0255"><img id="ib0255" file="imgb0255.tif" wi="165" he="88" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="173"> -->
dans lesquelles Ar, Y et R1 à R8 sont identiques aux définitions concernant Ar, Y et R1 à R8 de la Formule 1 et de la Formule 3.</claim-text></claim><claim id="c-fr-01-0006" num="0006"><claim-text>Composé selon la revendication 1, dans lequel le composé de Formule 1 est représenté par la Formule 2-2 suivante et le composé de Formule 3 est représenté par la formule 3-2 suivante :
<chemistry id="chem0256" num="0256"><img id="ib0256" file="imgb0256.tif" wi="158" he="86" img-content="chem" img-format="tif"/></chemistry>
dans lesquelles Ar, Y et R1 à R8 sont identiques aux définitions concernant Ar, Y et R1 à R8 de la Formule 1 ou de la Formule 3.</claim-text></claim><claim id="c-fr-01-0007" num="0007"><claim-text>Composé selon la revendication 1, dans lequel quand Y de la Formule 1 ou de la Formule 3 est une arylamine, il est l'un quelconque des groupes suivants :<!-- EPO <DP n="174"> -->
<chemistry id="chem0257" num="0257"><img id="ib0257" file="imgb0257.tif" wi="165" he="175" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="175"> -->
<chemistry id="chem0258" num="0258"><img id="ib0258" file="imgb0258.tif" wi="165" he="196" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="176"> -->
<chemistry id="chem0259" num="0259"><img id="ib0259" file="imgb0259.tif" wi="165" he="164" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="177"> -->
<chemistry id="chem0260" num="0260"><img id="ib0260" file="imgb0260.tif" wi="165" he="199" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="178"> -->
<chemistry id="chem0261" num="0261"><img id="ib0261" file="imgb0261.tif" wi="165" he="211" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="179"> -->
<chemistry id="chem0262" num="0262"><img id="ib0262" file="imgb0262.tif" wi="165" he="211" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="180"> -->
<chemistry id="chem0263" num="0263"><img id="ib0263" file="imgb0263.tif" wi="165" he="211" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="181"> -->
<chemistry id="chem0264" num="0264"><img id="ib0264" file="imgb0264.tif" wi="165" he="199" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="182"> -->
<chemistry id="chem0265" num="0265"><img id="ib0265" file="imgb0265.tif" wi="165" he="199" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="183"> -->
<chemistry id="chem0266" num="0266"><img id="ib0266" file="imgb0266.tif" wi="165" he="211" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="184"> -->
<chemistry id="chem0267" num="0267"><img id="ib0267" file="imgb0267.tif" wi="160" he="204" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="185"> -->
<chemistry id="chem0268" num="0268"><img id="ib0268" file="imgb0268.tif" wi="160" he="204" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="186"> -->
<chemistry id="chem0269" num="0269"><img id="ib0269" file="imgb0269.tif" wi="165" he="209" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="187"> -->
<chemistry id="chem0270" num="0270"><img id="ib0270" file="imgb0270.tif" wi="165" he="178" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="188"> -->
<chemistry id="chem0271" num="0271"><img id="ib0271" file="imgb0271.tif" wi="165" he="178" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="189"> -->
<chemistry id="chem0272" num="0272"><img id="ib0272" file="imgb0272.tif" wi="163" he="183" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="190"> -->
<chemistry id="chem0273" num="0273"><img id="ib0273" file="imgb0273.tif" wi="162" he="186" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="191"> -->
<chemistry id="chem0274" num="0274"><img id="ib0274" file="imgb0274.tif" wi="163" he="178" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="192"> -->
<chemistry id="chem0275" num="0275"><img id="ib0275" file="imgb0275.tif" wi="156" he="190" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="193"> -->
<chemistry id="chem0276" num="0276"><img id="ib0276" file="imgb0276.tif" wi="159" he="198" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="194"> -->
<chemistry id="chem0277" num="0277"><img id="ib0277" file="imgb0277.tif" wi="165" he="192" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="195"> -->
<chemistry id="chem0278" num="0278"><img id="ib0278" file="imgb0278.tif" wi="156" he="176" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="196"> -->
<chemistry id="chem0279" num="0279"><img id="ib0279" file="imgb0279.tif" wi="162" he="168" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="197"> -->
<chemistry id="chem0280" num="0280"><img id="ib0280" file="imgb0280.tif" wi="165" he="200" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="198"> -->
<chemistry id="chem0281" num="0281"><img id="ib0281" file="imgb0281.tif" wi="162" he="182" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="199"> -->
<chemistry id="chem0282" num="0282"><img id="ib0282" file="imgb0282.tif" wi="163" he="192" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="200"> -->
<chemistry id="chem0283" num="0283"><img id="ib0283" file="imgb0283.tif" wi="159" he="189" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="201"> -->
<chemistry id="chem0284" num="0284"><img id="ib0284" file="imgb0284.tif" wi="161" he="188" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="202"> -->
<chemistry id="chem0285" num="0285"><img id="ib0285" file="imgb0285.tif" wi="165" he="175" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="203"> -->
<chemistry id="chem0286" num="0286"><img id="ib0286" file="imgb0286.tif" wi="164" he="189" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="204"> -->
<chemistry id="chem0287" num="0287"><img id="ib0287" file="imgb0287.tif" wi="165" he="189" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="205"> -->
<chemistry id="chem0288" num="0288"><img id="ib0288" file="imgb0288.tif" wi="165" he="120" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-fr-01-0008" num="0008"><claim-text>Composé selon la revendication 1, dans lequel Ar de la Formule 1 ou de la Formule 3 est le phénylène.</claim-text></claim><claim id="c-fr-01-0009" num="0009"><claim-text>Composé selon la revendication 1, dans lequel le composé de la Formule 1 ou de la Formule 3 est un quelconque composé de la Formule 6 à la Formule 13 suivantes :<!-- EPO <DP n="206"> -->
<chemistry id="chem0289" num="0289"><img id="ib0289" file="imgb0289.tif" wi="105" he="63" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0290" num="0290"><img id="ib0290" file="imgb0290.tif" wi="105" he="67" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0291" num="0291"><img id="ib0291" file="imgb0291.tif" wi="105" he="83" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="207"> -->
<chemistry id="chem0292" num="0292"><img id="ib0292" file="imgb0292.tif" wi="102" he="122" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0293" num="0293"><img id="ib0293" file="imgb0293.tif" wi="124" he="91" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="208"> -->
<chemistry id="chem0294" num="0294"><img id="ib0294" file="imgb0294.tif" wi="106" he="111" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0295" num="0295"><img id="ib0295" file="imgb0295.tif" wi="130" he="110" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="209"> -->
<chemistry id="chem0296" num="0296"><img id="ib0296" file="imgb0296.tif" wi="105" he="74" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-fr-01-0010" num="0010"><claim-text>Dispositif électroluminescent organique qui comprend une première électrode, une couche de matière organique qui comprend une ou plusieurs couches ayant une couche électroluminescente, et une seconde électrode en couches séquentielles,<br/>
dans lequel le dispositif électroluminescent organique comprend une ou plusieurs couches de la couche de matière organique qui comprend une couche de transport de trous, une couche d'injection de trous, une couche de transport et d'injection de trous, ou une couche d'injection et de transport d'électrons, et<br/>
la couche de transport de trous, la couche d'injection de trous, la couche de transport et d'injection de trous, la couche d'injection et de transport d'électrons, ou la couche électroluminescente comprennent le composé de la Formule 1, de la Formule 3, de la Formule 4 ou de la Formule 5 selon la revendication 1.</claim-text></claim></claims><drawings mxw-id="PDW16671882" load-source="patent-office"><!-- EPO <DP n="210"> --><figure id="f0001" num="1,2"><img id="if0001" file="imgf0001.tif" wi="158" he="125" img-content="drawing" img-format="tif"/></figure></drawings><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
